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Egress is a crucial phase of the Toxoplasma gondii intracellular lytic cycle. This is 
a process that drives inflammation and is strongly associated with the pathogenesis 
observed during toxoplasmosis. Despite the link between this process and virulence, 
little is known about egress on a mechanistic or descriptive level. Previously published 
work suggested that the parasite utilizes a phospholipase, lecithin-cholesterol acyl- 
transferase (LCAT), for contributions to parasite growth, virulence, and egress. LCAT is 
secreted from the parasite’s dense granules, but unlike other LCAT orthologues, this 
enzyme is proteolytically processed into two fragments.  This processing is predicted to 
occur within a unique 140 amino acid insertion found inside LCAT’s conserved catalytic 
domain. Here we present evidence from several independent mutant parasite lines 
confirming a role for LCAT in efficient egress, although no defects in growth or virulence 
were apparent. We also show via genetic complementation that the catalytic activity of 
LCAT is required for its role in parasite egress. Additionally, a genetically encoded 
calcium sensor revealed a potential delay in calcium signaling during egress in 
parasites lacking LCAT. This work solidifies the contribution of LCAT to egress of T. 
gondii tachyzoites and identifies a new connection in the calcium signaling network.  











1.1 The apicomplexans 
Found within the eukaryotic tree of life, branching off just before the divergence 
of plants and animals, are a small clade of unicellular pathogens belonging to the 
phylum Apicomplexa. This taxonomic group is where a number of clinically and 
agriculturally relevant microbes such as Plasmodium falciparum (malaria), 
Cryptosporidium spp. (cryptosporidiosis), Babesia spp. (babesiosis), and Toxoplasma 
gondii (toxoplasmosis) reside. These eukaryotic pathogens are named as such because 
of a common apically located plastid-like organelle, and share a number of important 
features like the use of a powerful actin-based motility system, a complex set of apical 
secretory organelles: the micronemes, rhoptries, and dense granules, and are all 
obligate intracellular parasites. Another hallmark of this phylum is its lytic intracellular 
lifecycle, which consists of parasite invasion into a host cell, replication of the parasite, 
and ultimately a dynamic egress event that leads to the cytolytic death of the parasitized 
host cell. 
 
1.2 Infection by the tachyzoite 
Although many stages of the parasite are found within a complete lifecycle, the 
most commonly studied forms of T. gondii in the laboratory are the tachyzoites. This 
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stage is responsible for the associated disease, toxoplasmosis. The term tachyzoite 
comes from Greek (tachos = speed) and refers to the high metabolism and reproductive 
rate seen in this form of the parasite. The infection begins with host cell invasion as the 
parasite uses adhesion molecules on its surface to attach to a host cell and correctly 
orient its apical end towards the target cell 1, 2. Following attachment the tachyzoite 
secretes a number of proteins from the apical microneme and rhoptry organelles to form 
an invasion complex called the “moving junction” 3. This complex serves as an anchor 
point on the host cell which is coupled to the parasite’s underlying actin-myosin based 
motor system. As this complex is trafficked to the posterior end of the tachyzoite, the 
parasite effectively “pulls” itself into the host cell, invaginating the host plasma 
membrane along the way. The invasion process is completed as the host plasma 
membrane (HPM) is pinched off behind the now intracellular parasite, forming the 
parasitophorous vacuolar membrane (PVM) 4, 5. Once within the parasitophorous 
vacuole (PV), additional proteins are secreted from a third set of secretory organelles 
called dense granules; straightforwardly named as such because of their dense 
appearance in electron micrographs. These GRA proteins are largely unexplored, and a 
distinguishing feature of identified GRA proteins is their lack of homology to proteins of 
known function. However, one prescribed role for GRA proteins is in the modification of 
the replicative niche and the PVM to optimize parasite growth and nutrient acquisition 6, 
7. Following invasion and replication, the intracellular lytic cycle is completed during 
egress, as the parasite escape the host cell confines and begin the cycle anew. This 
process shares many of the same aspects of invasion, as adhesins and effector 
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proteins are secreted from the micronemes, and the parasite’s motor system becomes 
active once again. 
 
1.3 Egress of Toxoplasma gondii 
Intracellular infection is a strategy with a number of risks and rewards. While 
intracellular, Toxoplasma is surrounded by a wealth of host nutrients to support its 
growth and is shielded from the host immune system; however, in order for the infection 
to spread to a neighboring cell or to a new host organism the parasite must escape its 
infected host cell in a process called egress. Historically, egress was thought of as a 
simple passive event in which a nutrient exhausted host cell was “popped” from within 
due to the increasing mechanical burden of the rapidly expanding PV. The escaping 
parasites must breach multiple barriers including the parasitophorous vacuolar 
membrane, the host plasma membrane, host endomembranous organelles (e.g. 
mitochondria, endoplasmic reticulum), and host cytoskeletal structures. Recently we 
have come to appreciate this event is an active process in which the parasite utilizes a 
number of tools.  
 
1.4 Host contributions to egress 
In a twist that is not unsurprising given the level of control many parasites impose 
onto their hosts; new evidence suggests that Toxoplasma is able to hijack host 
proteases to facilitate its own release. Initial observations were made showing a 
requirement of host calpain, a calcium-dependent protease that degrades cytoskeletal 
structures. The primary experiments illustrated a role for this enzyme in egress of 
Plasmodium falciparum. Subsequent work showed that when Toxoplasma infected 
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murine cells lacking calpain 1 (siRNA knockdown or mutant cell lines), egress was 
delayed in comparison to infection of wild type cells 8. A follow up study further explored 
this phenotype and found a role for a host G-protein coupled receptor (GPCR) at the 
head of a calcium signaling cascade involved in egress of both T. gondii and P. 
falciparum. Signaling through the GPCR led to activation of a phospholipase C (PLC) 
and protein kinase C (PKC). PKC dependent phosphorylation of α-adducin results in the 
destabilization of host cytoskeleton, followed by a calcium influx and finally, activation of 
host calpain-1 9. However, it needs to be pointed out that evidence for a parasite-
induced mechanism of GPCR activation was based solely on a loose association: the 
particular GPCR in question (Gαq subunit), can be activated by alpha ketoglutarate and 
succinate—both bi-products of the T. gondii TCA cycle. No direct role for these parasite-
derived molecules was shown; therefore these findings should be interpreted cautiously 
in the absence of additional data. 
 
1.5 Barriers to egress 
As previously mentioned, there are numerous lipid bilayers that Toxoplasma 
must circumvent in order to egress. As of yet only a single protein, perforin-like protein 1 
(PLP1), has been attributed to this process. PLP1 is secreted from the micronemes, 
most likely immediately prior to egress, and functions similarly to other pathogenic pore-
forming proteins by oligomerizing on target membranes before insertion as a large 
multimeric pore 10, 11. While genetic data clearly shows that PLP1 is both necessary and 
sufficient for permeabilization of the PVM, it is not yet known if PLP1 is sufficient for 
lysis of host membranes, functions cooperatively or in synergy with other egress factors, 
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and/or serves as a conduit for release of additional lytic factors or exchange of signaling 
molecules between the host and pathogen. More recent work has illustrated similar 
roles in egress for PLP1 homologues in various stages of the Plasmodium spp. lifecycle 
as well. 
In the Plasmodium egress framework, it is clear that secreted proteases help 
facilitate egress, as initial experiments showed that E64, an inhibitor of cysteine 
proteases, efficiently blocked parasite egress 12, and shortly thereafter was confirmed 
genetically as a number of proteases were implicated in egress of the malaria parasite 
13-16. As of yet there have been no mechanistic proposals for how these molecules 
contribute to parasites egress, but unpublished data from our lab show egress defects 
in two independent knockouts in T. gondii proteases, SUB1 and TLN4—although to a 
much lesser degree than the PLP1 knockout. 
 
1.6 The micronemes 
While much of the underlying mechanics of egress remain an enigma for all 
apicomplexan parasites, data examining this topic in Toxoplasma and Plasmodium spp. 
make it very clear that microneme secretion is vitally important to this process. In 
addition to secretion of PLP1, microneme secretion is crucial for parasite motility. The 
positive influence of motility on egress has long been considered important for efficient 
egress, yet not essential as chemically paralyzed Toxoplasma tachyzoites were 
observed rupturing the infected host cell 17. However more recent work on knockdowns 
of actin and associated motor proteins in Toxoplasma have demonstrated that 
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genetically paralyzed parasites are able to invade but are lethally impaired in their ability 
to egress 18. 
Perhaps the most telling evidence for the importance of microneme secretion 
comes from a chemical mutagenesis screen to generate a pool of temperature sensitive 
mutants; among these mutants they identified a clone that was unable to secrete 
microneme proteins at the restrictive temperature and was completely unable to egress 
at 40ºC. Using whole genome sequencing of the mutant the phenotype was traced to a 
protein called DOC2.1 19. This protein contains double C2 domains, a feature shared 
with proteins that facilitate membrane association in response to calcium. The proposed 
function of DOC2.1 is that it orchestrates membrane fusion and exocytosis of 
micronemes, perhaps in conjunction with other proteins such as SNAREs, in response 
to calcium.   
 
1.7 Signals for egress 
Parasite intracellular calcium has been recognized for quite some time as a key 
signal for microneme discharge 20, and accordingly this event has a prominent 
regulatory role in parasite invasion and egress. While these observations were initially 
made with chemical treatments that liberated stored calcium (calcium ionophores, 
thapsigargin), the explosion of genomic data in recent years has revealed an 
apicomplexan genome rich with proteins containing known calcium-binding domains. 
Pharmacological studies in Toxoplasma have shown the presence of a nifedipine-
sensitive calcium channel 21 as well as PLC enzymes that generate IP3 22. Importantly, 
the parasite itself responds to IP3 treatment with calcium release 23. In addition to IP3, 
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another molecule known to play a role in calcium signal amplification is cyclic ADP 
Ribose (cADPR), and again T. gondii undergoes a calcium response upon treatment 
with this molecule 24. While pharmacological data suggests the existence of these 
pathways, no IP3 receptors or cADPR receptors have been identified, and there are no 
obvious homologues to these proteins in the Apicomplexan genome. 
While calcium has long been implicated in microneme secretion and egress, it 
wasn’t until recently that some of the underlying factors have been reported. The Sibley 
group identified a calcium-dependent protein kinase (CDPK1) that acts downstream of 
calcium as a messenger and is essential for secretion of the micronemes 25. Shortly 
thereafter work expanding on this family was published as three independent groups 
detailed the role of another calcium-dependent protein kinase, CDPK3 26-28. All three 
groups found that CDPK3 was essential for microneme secretion while the parasite was 
intracellular (relevant to egress), but dispensable for microneme exocytosis while 
extracellular (relevant to invasion); and that CDPK3 is capable of sensing a drop in 
environmental K+ concentrations in the host cytosol 26. Sensing of environmental K+ 
brings up an important point in what the natural signal is for parasite egress. Historically, 
study of egress in the lab has relied on the artificial induction of egress by forcing the 
parasite to release calcium from intracellular stores. However, multiple groups have 
published that loss of host cell K+ can trigger this event 29, 30, and have postulated that in 
vivo potassium loss may be a signal that an infected host cell is under immune attack. 
In an event called externally triggered egress (ETE), parasites that are infecting 
macrophages or monocytes that come under immune attack through perforin or death 
ligand (Fas) signaling will initiate egress; 31, 32. Interestingly the consequences of ETE 
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are unclear; on one hand ETE seems to be a survival mechanism for the parasite, 
serving as a convenient way to escape from immune clearance. On the other hand, in a 
process called haven disruption, parasites that underwent rapid cycles of egress and 
reinfection were selectively eliminated in vivo 31.  
In the absence of immune pressure, the parasite may be able to use endogenous 
clues to initiate calcium-dependent egress through the hormone abscisic acid (ABA) 33. 
ABA levels within the parasite are relatively low except in more mature vacuoles prior to 
egress and are thought to act by inducing the production of the previously mentioned 
cADPR. 
 
1.8 A new player in egress 
Despite the important role of egress in the tachyzoites intracellular lifestyle, this 
process remains largely enigmatic as only a single secreted factor, PLP1 has been 
mechanistically described 10. This notable gap drove a search for additional secreted 
factors, which led us to a parasite-derived phospholipase: annotated within the 
database (ToxoDB) as lecithin-cholesterol acyltransferase (LCAT). A Plasmodium 
orthologue of LCAT was shown to be an active phospholipase that plays a pivotal role in 
the murine model of malaria34. However, this protein does not seem to be necessary for 
Plasmodium sporozoite egress, but instead is surface localized and involved in cell 
traversal—a cell migratory process with many analogies to T. gondii egress.   
Consistent with our hypothesis we showed that ∆lcat tachyzoites are delayed in 
their ability to egress from infected fibroblasts in vitro 35. While this discovery represents 
the first description of a phospholipase utilized during egress by an apicomplexan 
    9 
parasite, the use of lytic molecules such as pore-forming toxins (PFTs) and 
phospholipases shared among many clinical intracellular pathogens 36. The model 
system in this regard has been Listeria monocytogenes, which uses the pore-forming 
toxin LLO, and two phospholipase C (PLC) enzymes, PI-PLC and PC-PLC to escape 
limiting vacuoles after internalization into the host cell37. Despite clear thematic 
similarities, there are at least two important differences between Toxoplasma LCAT and 
L. monocytogenes PLCs. First, Listeria PLCs attack the C1 position, generating the 
intracellular signaling molecules DAG and IP3. In contrast LCAT displays phospholipase 
A2 (PLA2) activity 35, which generates lysophospholipid and releases a free fatty acid 
from the C2 position—neither of which have any implicated roles in intracellular 
signaling. However, lysophospholipid products from phospholipase reactions have been 
shown to have cytolytic activity 38. Second, L. monocytogenes escapes its vacuole 
shortly after invasion of the host cell, while Toxoplasma presumably secretes LCAT 
shortly after invasion and replicates for up to 60 h in vitro before initiating egress. This 
suggests there are intrinsic differences in how the activities of these two molecules are 
regulated. One potential method the parasite may employ to regulate the activity of 
egress effector proteins is by modulating a pH drop within the parasitophorous vacuole 
39. Importantly, in studies using the human orthologue of LCAT, a drop in pH enhances 
the enzyme’s activity by promoting membrane binding through an electrostatic 
interaction with negatively charged lipids 40. 
In addition to a conserved PLA2 domain, TgLCAT also possesses a lipase motif, 
AHSLG, that is characteristic of LPLA2 enzymes and has a conserved catalytic triad of 
SDH. TgLCAT is secreted from the parasite’s dense granules, but in contrast to known 
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members of the PLA2 family, the parasite protein is cleaved into two fragments post-
secretion 35. To gain a perspective on how the parasite utilizes this protein during the 
tachyzoite stage of infection, we examined the phenotype of parasite strains lacking the 
lcat coding sequence in the acute stage of the infection, the tachyzoite. Our results 
suggest that TgLCAT plays a positive role in facilitating parasite egress from the host 
cell, and this phenotype is potentially modulated by altered calcium signaling within the 
tachyzoite. We were not able to observe any defects in the ability of these knockout 
parasites to replicate or cause disease in the mouse model of infection, suggesting that 









Figure 1-1. Intracellular schematic of the tachyzoite.  Schematic illustrating host cell infection by 
T. gondii and relevant structures to egress. HPM = host plasma membrane; PV = parasitophorous 
vacuole; PVM = parasitophorous vacuolar membrane 






Toxoplasma gondii LCAT primarily 
contributes to tachyzoite egress 
 
2.1 Introduction 
Toxoplasma gondii is an obligate intracellular parasite that infects a wide range 
of host animals, including humans. This parasite is estimated to infect up to 1 in 3 
people worldwide 41, who are presumed to harbor the infection for the remainder of their 
lifetime. Toxoplasma commonly infects humans congenitally, through the ingestion of 
oocysts shed in the feces of infected felines, or from consumption of undercooked meat 
that contains tissue cysts 42. For T. gondii, and other intracellular pathogens, egress 
represents a crucial step of the lifecycle, which must occur in order for the parasite to 
infect new host cells. With this in mind it is not surprising that intracellular microbes 
have evolved numerous approaches and strategies to complete this task 36. These 
different approaches have vastly different impacts on the host and the damage-
response to infection 43. One such strategy utilized by protozoan parasites and 
extensively within Toxoplasma’s apicomplexan phylum is cytolytic egress. This event in 
particular results in massive release of inflammatory signals from cell death and tissue 
destruction. The resulting pyrogenic immune response is a hallmark of both 
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toxoplasmosis and malaria, caused by the related apicomplexan Plasmodium 
falciparum. While infection of a healthy adult is typically benign, toxoplasmosis can be 
disastrous among immunocompromised patients or those infected congenitally. 
Common manifestations of pathogenesis seen include potentially fatal toxoplasmic 
encephalitis and retinal destruction, frequently observed among congenitally-infected 
individuals 44-46. Indeed, the importance of a controlling host immune response is 
illustrated while examining the devastating affect of toxoplasmosis on the mortality of 
HIV-AIDS patients in the pre-antiretroviral (HAART) era 47-49, an observation that 
underscores the need for robust monitoring of tissue transplant and/or chemotherapy 
patients today. 
At the center of the pathogenesis seen during toxoplasmosis, is the lytic cycle of 
Toxoplasma. This cycle begins with the active invasion of the parasite into a new host 
cell, and the formation of an intracellular replicative niche called the parasitophorous 
vacuole (PV), formed from the host plasma membrane during invasion 50. After 
replication within the sequestered PV, the tachyzoites actively egress from the host cell 
and begin the cycle anew by invading nearby host cells. In many aspects invasion and 
egress are similar events and rely on secretion of the parasite’s micronemes and 
parasite motility, both processes dependent on activation of intracellular calcium 
signaling pathways 51. Egress requires the breakdown of two notable membrane 
barriers: the parasitophorous vacuolar membrane (PVM) and the host plasma 
membrane (HPM). However, outside of the microneme derived perforin-like protein 1 
(PLP1) which permeabilizes the PVM 10 effector molecules directly involved in this 
process have not been thoroughly defined.  
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Lecithin-cholesterol acyl transferase (LCAT) was originally described in 
Plasmodium berghei as a phospholipase named “PL”, in a screen to identify sporozoite 
proteins involved in the establishment of the infection 34. More recently this 
phospholipase has been tied to permeabilization of the PVM during Plasmodium 
merozoite egress from hepatocytes 52. Since then, additional work has been published 
focusing on the Toxoplasma ortholog LCAT. A mutant strain lacking LCAT showed 
slower growth based on fewer parasites per PV and smaller plaque area, a defect in 
egress, and a notable loss in virulence manifested by 70% survival of mice infected with 
mutant strains versus 0% survival of those infected with the parental strain 35.  
To understand in greater detail the secreted effectors that Toxoplasma gondii 
utilizes during egress, we have focused our attention on TgLCAT, hereafter referred to 
simply as “LCAT”. During the course of this study, we consistently observed that 
parasites lacking LCAT were unable to complete the egress event as efficiently as their 
wildtype counterparts. However, unlike the previously described LCAT mutant 35, the 
new strains show normal parasite replication in vitro and no loss of virulence in mice. 
Interestingly, we also establish a link between expression of LCAT and the kinetics of 
intracellular calcium signaling. This is based on ∆lcat parasites displaying a lag in 
calcium signaling in response to zaprinast treatment as measured via a genetically 
encoded calcium sensor. These findings establish a new connection between a 
secreted phospholipase and calcium signaling in Toxoplasma. 
 
2.2 Results 
2.2.1 Genetic removal and complementation of LCAT 
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Previous work regarding LCAT focused on parasites that were genetically 
ablated in the wild-type RH background 35. This approach led to the generation of a 
knockout line that might contain additional genetic disruptions and a complemented 
strain that substantially overexpressed active LCAT. Also, the previous study did not 
include a complementation strategy with a catalytically inert mutant. We reasoned that 
these issues would complicate downstream analyses and that, accurately assessing the 
function of LCAT would require remaking the knockout in the RH∆ku80 line, which 
allows more precise gene deletion and complementation 53. The LCAT locus 
(EuPathDB: TGME49_272420) was modified by double homologous integration to 
replace the LCAT coding region with the dihydrofolate reductase (dhfr) selectable 
marker. After transfection of a linear knockout construct (Figure 2-1A) constructed by 
fusion PCR and pyrimethamine selection, the absence of LCAT was confirmed 
genetically via PCR amplification of the coding sequence and at the protein level as 
seen by western blot (Figure 2-1C,D). This RH∆ku80∆lcat strain was then 
complemented with C-terminally HA tagged WT (∆lcatLCAT-HA) and a mutant allele 
(∆lcatLCAT*-HA), which harbors an S332A point mutation predicted to destroy lytic 
activity from the active site serine. These constructs were integrated into the “empty” 
∆ku80 locus by double homologous recombination (Figure 2-1B) and incorporation into 
the genome was confirmed by PCR detection of the shortened cDNA within the ku80 
locus and by restoration of protein expression, albeit slightly shifted in size due to the 
addition of the epitope tag (Figure 2-1C,D). 
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LCAT mutants show normal plaque formation and replication. We next per-
formed plaque assays to test the LCAT-deficient parasites for any broad defects through
successive lytic cycles. Confluent monolayers of human foreskin fibroblasts (HFFs) were
infected, and the parasites were allowed to replicate undisturbed for 7 days before
fixation and staining of the monolayer (Fig. 2A). Quantification of the resulting plaque
sizes showed no difference between parental, knockout, or either one of the comple-
mented strains (Fig. 2B). These results indicate the absence of LCAT does not affect the
ability of tachyzoites to efficiently progress through the lytic cycle in vitro. While the
results were not suggestive of a growth defect, we shifted to an intracellular replication
assay to examine the rate of parasite division between strains more precisely. Parasite
replication was directly measured by infecting confluent monolayers of HFFs and
allowing replication to occur for either 16 or 32 h before fixation and manual quanti-
fication of parasites per vacuole via fluorescence microscopy. No differences in the
replication rate of ∆lcat parasites compared to parental or complemented strains were
found (Fig. 2C and D).
LCAT-deficient parasites display normal virulence in the murine model.We next
sought to measure virulence of the new ∆lcat strain in the acute model of murine
infection. Due to the highly virulent nature of the type I strain background, we chose
to use a low dose of 10 tachyzoites administered subcutaneously to BALB/c mice. By
10 days postinfection, infected mice were displaying signs of morbidity, and the mice
FIG 1 Generation of ∆lcat and ∆lcat complemented lines. (A) Schematic representation of the linear
knockout construct and generation of the LCAT knockout by double homologous integration of dhfr at
the lcat locus. e2, exon 2. (B) Schematic representation of the complementation of the ∆lcat strain,
showing the lcat cDNA under direction of its endogenous 5= and 3= untranslated regions (UTRs), being
driven to integrate into the “empty” ku80 locus by double homologous recombination. (C) PCR showing
genetic confirmation of the knockout and complemented strains by amplification of the coding se-
quence (CDS) (primer pair A), and detection of the 5= and 3= arms of the complementation construct
within the ku80 locus (primer pairs B and C, respectively). (D) Western blot confirming the loss of and
restoration of LCAT expression in the knockout and complemented strains, respectively. The positions of
molecular ●●●●●●● markers (in ●●●●●●●) are indicated to the left of the blot. The arrows to the right
of the blot indicate specific full-length and proteolytically processed bands (slightly shifted in the
complemented strains, due to the addition of HA epitope tag). The asterisk denotes a nonspecific band.
!-LCAT, anti-LCAT.
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Figure 2-1 Generation of ∆l at and ∆lcat complement d lines. (A) Schematic 
representation of the linear knockout construct and generation of the LCAT knockout 
by double homologous integration of dhfr at the lcat locus. e2, exon 2. (B) Schematic 
representation of the complementa ion of the ∆lcat str in, showing the lcat cDNA under 
direction of its endogenous 5= and 3= untranslated regions (UTRs), being driven to 
integrate into the “empty” ku80 locus by double homologous recombination. (C) PCR 
showing genetic confirmation of the knockout and complemented strains by 
amplification of he coding se- quence (CDS) ( rimer pair A), a d detection of the 5= 
and 3= arms of the complementation construct within the ku80 locus (primer pairs B 
and C, respectively). (D) Western blot confirming the loss of and restoration of LCAT 
expression in the knockout and complemented strains, respectively. The positions of 
molecular weight markers (in kDa) are indicated to the left of the blot. The arrows to 
the right of the blot indicate specific full-length and proteolytically processed bands 
(slightly shifted in the complemented strains, due to the addition of HA epitope tag). 
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2.2.2 LCAT mutants show normal plaque formation and replication 
We next performed plaque assays to test the LCAT deficient parasites for any 
broad defects through successive lytic cycles. Confluent monolayers of human foreskin 
fibroblasts (HFFs) were infected, and the parasites were allowed to replicate 
undisturbed for 7 days before fixation and staining of the monolayer (Figure 2-2A). 
Quantification of the resulting plaque sizes showed no difference between parental, 
knockout, or either of the complemented strains (Figure 2-2B). These results indicate 
the absence of LCAT does not affect the ability of tachyzoites to efficiently progress 
through the lytic cycle in vitro. While the results were not suggestive of a growth defect, 
we shifted to an intracellular replication assay to more precisely examine the rate of 
parasite division between strains. Parasite replication was directly measured by 
infecting confluent monolayers of HFFs and allowing replication to occur for either 16 or 
32 hours before fixation and manual quantification of parasites per vacuole via 
fluorescence microscopy. No differences in the replication rate of ∆lcat parasites 
compared to parental or complemented strains were found (Figure 2-2C,D). 
  





2.2.3 LCAT deficient parasites display normal virulence in the murine model 
We next sought to measure virulence of the new ∆lcat strain in the acute model 
of murine infection. Due to the highly virulent nature of the type I strain background, we 
chose to use a low dose of 10 tachyzoites administered subcutaneously to BALB/c 
mice. By 10 days post infection infected mice were displaying signs of morbidity, and 
were euthanized by 10 – 15 days post infection (Figure 2-3A). No statistically significant 
were euthanized by 10 to 15 days postinfection. No statistically significant differences
in survival were seen, as mice infected with parental, knockout, or complemented
strains succumbed to the infection with similar kinetics. To investigate a potential role
for LCAT in vivo more thoroughly, we recreated the knockout in the wild-type RH
background. LCAT-deficient parasites were generated using the clustered regularly
interspaced short palindromic repeat (CRISPR)-Cas9 system (18) by targeting the Cas9
nuclease via a single guide RNA (sgRNA) to a region near the 5= end of lcat exon 1
(Fig. 3B). After transfection of the plasmid containing the lcat sgRNA, we were able to
isolate parasite clones that no longer expressed the LCAT protein, as confirmed by
Western blotting shown for one such clone (Fig. 3C). No difference in plaque area was
observed betwe n wild-type nd RH∆lcat tachyzoites, c nfirming that LCAT-deficient
parasites progress normally through the lytic cycles, similar to our initial observations
in the ∆ku80 background (Fig. 3D). In lieu of further quantification by counting parasites
per vacuole as done previously, we chose to use an in vitro competition assay which,
over serial passages, should be a more sensitive method of quantifying parasite growth.
Briefly, RH∆lcat parasites were transfected with a plasmid allowing for stable expression
of green fluorescent protein (GFP) to allow for easy identification and differentiation of
RH versus RH∆lcat parasites. Both parental and knockout parasites were inoculated into
T25 flasks of confluent HFFs, and after each lysis, parasites were collected for quanti-
fication via fluorescence microscopy. The results of the in vitro competition assay mirror
what was seen in previous growth assays, as there were no significant differences in
relative abundance after serial coculture (Fig. 3E).
To measure virulence of the new RH∆lcat strain, we injected BALB/c mice subcuta-
neously with 10 or 50 tachyzoites of wild-type RH or two clones of RH∆lcat. Again, no
statistically significant differences were elucidated between any of the strains (Fig. 3F
and G). This experiment was repeated in outbred mice, as we infected Swiss Webster
FIG 2 LCAT does not play a role in growth or replication. (A) LCAT knockout and complemented strains form normal plaques over a 7-day
infection of HFFs. (B) Quantification of the plaque area via ImageJ showed no significant differences between parental, knockout, or
complemented strains. Data shown are means ! standard errors of the means (SEM) (error bars) from three or four biological replicates.
The values were not significantly different (n.s.). (C and D) Quantification of parasite replication by counting parasites per vacuole at 16 h
(C) or 32 h (D). Data represent pooled data from three biological replicates, each with at least 250 vacuoles per strain counted. No
significant differences were found using Pearson’s chi-squared test.
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Figure 2-2. LCAT does n t play a role in gr wth or r pli at on.  
(A) LCAT knockout and complemented strains form normal plaques over a 7-day infection of 
HFFs. (B) Quantification of the plaque area via ImageJ showed no significant differences 
between parental, knockout, or complemented strains. Data shown are means standard errors 
of th  means (SEM) (error bars) from three or four biological replicates. The values were not 
significantly differ nt (n.s.). (C and D) Quantificati n f parasit  replication by counting 
parasites per vacuole at 16 h (C) or 32 h (D). Data represent oled data from three biological 
replicates, each with at least 250 vacuoles per strain counted. No significant differences were 
found using Pearson’s chi-squar d test.  
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differences in survival were seen as mice infected with parental, knockout, or 
complemented strains succumbed to the infection with similar kinetics. To more 
thoroughly investigate a potential role for LCAT in vivo, we re-created the knockout in 
the wild-type RH background. LCAT deficient parasites were generated using the 
CRISPR-Cas9 system 54, by targeting the Cas9 nuclease via a single guide RNA to a 
region near the 5’ end of lcat exon 1 (Figure 2-3B). After transfection of the plasmid 
containing the lcat sgRNA, we were able to isolate parasite clones that no longer 
expressed the LCAT protein, as confirmed by western blot shown for one such clone 
(Figure 2-3C). No difference in plaque area was observed between wild-type and 
RH∆lcat tachyzoites, confirming that LCAT deficient parasites progress normally 
through the lytic cycles and our initial observations in the ∆ku80 background (Figure 2-
3D). In lieu of further quantification by counting parasites per vacuole as done 
previously, we chose to use an in vitro competition assay which, over serial passages, 
should be a more sensitive method of quantifying parasite growth. Briefly, RH∆lcat 
parasites were transfected with a plasmid allowing for stable expression of GFP to allow 
for easy identification and differentiation of RH vs. RH∆lcat parasites. Both parental and 
knockout parasites were inoculated into T25s of confluent HFFs, and after each lysis 
parasites were collected for quantification via fluorescence microscopy. The results of 
the in vitro competition assay mirror what was seen in previous growth assays, as there 
were no significant differences in relative abundance after serial co-culture (Figure 2-
3D). 
To measure virulence of the new RH∆lcat strain we injected BALB/c mice 
subcutaneously with 10 or 50 tachyzoites of wild-type or two clones of RH∆lcat. Again, 
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no statistically significant differences were elucidated between any of the strains 
(Figure 2-3F,G). This experiment was repeated in outbred mice, as we infected Swiss 
Webster mice with 50 tachyzoites of wild-type or a single clone of RH∆lcat, with very 
similar results being observed (Figure 2-3H). Collectively, after testing the LCAT 
knockout from multiple parasite strain backgrounds, in the context of multiple mouse 
strain backgrounds, our findings suggest that LCAT does not contribute to Toxoplasma 
virulence. 
 
2.2.4 Parasites lacking LCAT display a consistent phenotype in impaired egress 
We next examined to what extent the loss of LCAT expression affects parasite 
egress from the host cell. To determine this we infected HFF monolayers in 96-well 
plates with either WT (RH or RH∆ku80) or knockout (RH∆lcat or RH∆ku80∆lcat) 
parasites. After 30 hours of replication the infected monolayers were then treated with 
zaprinast to pharmacologically induce egress. Zaprinast is a phosphodiesterase 
inhibitor that induces egress by activation of the parasite protein kinase G (PKG) 27. The 
culture supernatant was collected and assayed for lactate dehydrogenase (LDH) 
content as a function of egress (host membrane damage). The results showed ~40% 
and ~55% in zaprinast-induced LDH release by RH∆lcat and  
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Figure 2-3 LCAT does not contribute to virulence in the murine model. (A) Survival data of 
infected mice. Female BALB/c mice were infected subcutaneously with 10 tachyzoites of the 
indicated strain, and survival was monitored over the following weeks. The data represent 10 
mice per group pooled from two biological replicates. (B) Schematic illustrating the use of 
CRISPR-Cas9 for targeted disruption of the lcat coding sequence. A 20-bp sgRNA was used to 
direct the nuclease to the 5= region of exon 1. (C) Western blot confirming the loss of LCAT 
expression after CRISPR-Cas9-mediated disruption. The asterisk denotes a nonspecific band. 
(D) Quantification of plaque area in wild-type RH and RHΔlcat. (E) Parasite growth as 
measured by an in vitro competition assay showing the relative abundance of RH and RHΔlcat 
across three serial passages. (F) Survival of female BALB/c mice infected with 10 tachyzoites 
subcutaneously. (G) Survival of female BALB/c mice infected with 50 tachyzoites 
subcutaneously. Data in panels F and G are from 10 mice per group pooled from two biological 
replicates infected with wild-type or two separate clones of RHΔlcat. (H) Survival of female 
outbred Swiss Webster mice infected with 10 tachyzoites subcutaneously. The data are from 
five mice in one experiment. No significant differences were observed in growth (Student’s t 
test) or survival (Kaplan-Meier analysis).  
 
mice with 50 tachyzoites of wild-type RH or a singl clone of RH∆lcat with very similar
res l s (Fig. 3H). Collectively, aft r testing the LCAT knockout from multiple parasite
strain backgrounds in the contex of multiple mouse strain backgrounds, our findings
suggest that LCAT does not contribute o Toxoplasma virulence.
Parasites lacking LCAT display a consistent phenotype in impai d egr ss. We
next examined to what extent the loss of LCAT expression affects parasite egress from
FIG 3 LCAT does not contribute to virulence in the murine model. (A) Survival data of infected mice. Female BALB/c mice were infected
subcutaneously with 10 tachyzoites of the indicated strain, and survival was monitored over the following weeks. The data represent 10
mice per group pooled from two biological replicates. (B) Schematic illustrating the use of CRISPR-Cas9 for targeted disruption of the lcat
coding sequence. A 20-bp sgRNA was used to direct the nuclease to the 5= region of exon 1. (C) Western blot confirming the loss of LCAT
expression after CRISPR-Cas9-mediated disruption. The asterisk denotes a nonspecific band. (D) Quantification of plaque area in wild-type
RH and RH∆lcat. (E) Parasite growth as measured by an in vitro competition assay showing the relative abundance of RH and RH∆lcat
across three serial passages. (F) Survival of female BALB/c mice infected with 10 tachyzoites subcutaneously. (G) Survival of female BALB/c
mice infected with 50 tachyzoites subcutaneously. Data in panels F and G are from 10 mice per group pooled from two biological
r plicates infected with wild-type or two separate cl nes of RH∆lcat. (H) Survival of female utbred Swiss Webs er mice infected with 10
tachyzoites subcutaneously. The data are from five mice in one experiment. No significant differences were observed in growth (Student’s
t test) or survival (Kaplan-Meier analysis).
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RH∆lcat∆ku80 parasites, respectively (Figure 2-4A,B). This phenotype was 
partially, yet significantly, restored upon complementation of the knockout with the 
wildtype version of LCAT but not with the catalytically inert mutant (Fig. 4B). These 
findings confirm a role for LCAT in Toxoplasma egress, and newly identify a 
requirement for LCAT activity in this event. 
the host cell. To determine this, we infected HFF monolayers in 96-well plates with
either WT (RH or RH∆ku80) or knockout (RH∆lcat or RH∆ku80∆lcat) parasites. After 30 h
of replication, the infected monolayers were then treated with zaprinast to induce
egress pharmacologically. Zaprinast is a phosphodiesterase inhibitor that induces
egress by activation of the parasite protein kinase G (PKG) (19). The culture supernatant
was collected and assayed for lactate dehydrogenase (LDH) content as a function of
egress (host membrane damage). The results showed ~40% and ~55% in zaprinast-
induced LDH release by RH∆lcat and RH∆lcat!ku80 parasites, respectively (Fig. 4A and
B). This phenotype was partially, yet significantly, restored upon complementation of
the knockout with the wild-type version of LCAT but not with the catalytically inert
mutant (Fig. 4B). These findings confirm a role for LCAT in Toxoplasma egress and newly
identify a requirement for LCAT enzymatic activity in this event.
DISCUSSION
As obligate intracellular pathogens, egress from the infected host cell is an absolute
requirement for apicomplexan parasites. Therefore, it comes as no surprise that these
parasites have evolved a multitude of specialized effector molecules to complete this
task. While currently only one such protein has been mechanistically described in
Toxoplasma (PLP1) (13, 20, 21), there have been suggested roles for a genetically
duplicated secreted nucleoside triphosphate hydrolase (22) that could act in signaling
or as an effector. Host calpain proteases have also been implicated, which are thought
to facilitate egress by selective degradation of the host cytoskeleton prior to egress (23,
24). The landscape of secreted egress effectors has become somewhat better defined
in the Plasmodium field, with roles being ascribed for secreted proteases such as SUB1,
members of the SERA family, and DPAP3 (25–27) in addition to several members of the
perforin-like protein family (28–30).
In 2005, a surface-localized phospholipase, Plasmodium berghei phospholipase
(PbPL), was described in P. berghei, which facilitates sporozoite cell traversal (14), and
was more recently shown to aid in merozoite egress from infected hepatocytes (15).
Subsequently, the Toxoplasma orthologue LCAT was shown to have a similar role in
egress of tachyzoites in vitro (16). In a continuation of that study, we have found a
consistent role for LCAT in parasite egress but were not able to identify a supporting
role in parasite replication or a noticeable role in vivo. One possible explanation is that
the original LCAT knockout was made in the RH strain, which can exhibit off-target
integration of knockout constructs. Replication and virulence phenotypes in the orig-
FIG 4 LCAT-deficient parasites are unable to efficiently egress from host cells. (A and B) Egress following
20 min of incubation with 57 !M zaprinast. Lactate dehydrogenase release following induction was used
as a measure for egress and normalized to wild-type RH (A) or RH∆ku80 (B). Statistical significance was
assigned by Student’s t test, Data shown are means " SEM (error bars) from three biological replicates
each with three technical replicates. Values that are significantly different (P # 0.05) by Student’s t test
are indicated by a bar and asterisk.
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Figure 2-4. LCAT-deficient parasites are unable to efficiently egre s from host cells. (A 
and B) Egress following 20 min of incubation with 57 M zaprinast. Lactate dehydrogenase 
release following induction was used as a measure for egress and normalized to wild-type RH 
(A) or RHΔku80 (B). Statistical significance was assigned by Student’s t test, Data shown are 
means SEM (error bars) from three biological replicates each with three technical replicates. 
Values that are significantly differ nt (P 0.05) by Student’s t test are indicated by a bar and 
asterisk.  
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2.2.5 Parasites lacking LCAT have altered calcium signaling kinetics 
To more thoroughly investigate the nature of the egress defect, we next sought to 
examine calcium signaling as this event has been well established as a central regulator 
of parasite motility and egress. To this end, lcat was again genetically ablated using 
CRISPR-Cas9, this time in a parasite line expressing a genetically encoded calcium 
sensor (GCaMP6f) (Figure 2-5A). This system allowed us to monitor calcium signaling 
in real time, as changes in intracellular calcium concentration during zaprinast-induced 
egress lead to a robust response of increased GCaMP fluorescence (Figure 2-5B). To 
analyze calcium signaling, HFF monolayers were infected for 30 hours prior to induction 
of egress by treatment with zaprinast. Calcium signaling was quantified as the time of 
maximum GCaMP intensity, as measured over the entire PV. We were able to detect a 
subtle difference in the timing of the peak signal (Figure 2-5C, upper panel), which was 
significantly exacerbated in the absence of extracellular calcium (Figure 2-5C, lower 
panel). While analyzing these data, we noted the resulting calcium traces (GCaMP 
intensity vs. time) could be binned into two types of response categories: monophasic 
and biphasic (Figure 2-5D). While the ratio of monophasic:biphasic response was 
roughly 1:1 for both wildtype and knockout strains, we chose to examine the kinetics of 
the biphasic response more closely by characterizing the elapsed time between the two 
peaks (Figure 2-5D). Once again we were able to detect a subtle phenotype that was 
significantly separated in the absence of extracellular calcium (Figure 2-5E). Further 
analysis of this phenotype led us to examine the biphasic vacuoles that successfully 
egressed during the 4-minute course of the experiment. After ranking egress as a 
percentage of the population over time (multiple pooled experiments), the findings 
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suggest the delay between these peaks observed in GCaMP∆lcat parasites contributes 
to a postponement of egress by these parasites (Figure 2-5F). Unfortunately, attempts 
to complement the phenotype generated data with a similar trend, but were not 
statistically significant. The GCaMP∆lcat strains were complemented using the same 
linearized complementation construct previously discussed (Figure 2-1), and although 
these new lines generated the expected egress phenotypes (Figure 2-5G), the calcium 
signaling phenotype did not (Figure 2-5H ). Figure 5 
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2.2.6. Altered Kinetics of PVM permeabilization in ∆lcat parasites 
To further examine the defects seen in the lcat knockout strains, we performed 
assays to monitor the integrity of the PVM in wild type and lcat knockout strains. To 
accomplish this, we used the wild type GCaMP and GCaMP∆lcat parasites previously 
described, and transiently transfected them with a construct encoding a soluble form of 
mCherry that is secreted into the PV (Figure 2-6A). Prior to egress while the PVM is 
intact, the mCherry signal is contained within the PV. Following treatment with zaprinast 
to stimulate egress and cytochalasin D to paralyze the parasites and halt motility, the 
intensity of this marker rapidly diminishes as mCherry diffuses out of the PV and into the 
host cytoplasm (Figure 2-6B). The inclusion of the GCaMP signal allowed us to use the 
maximum GFP intensity as a reference point, and compare the kinetics of when 
mCherry is released in the ∆lcat mutants. Median times of mCherry release between the 
two strains trended toward being different (Figure 2-6C) , but did not reach statistical 
significance due to small sample sizes and variability in the response times, especially 
for GCaMP parasites. 
  
Figure 2-5.  Parasites lacking LCAT have altered calcium signaling kinetics. (A) Western blot 
showing loss of LCAT expression in the GCaMP background following CRISPR-Cas9 disruption. (B) 
Example time-series of images showing a robust response in fluorescence intensity following 
treatment of GCaMP infected HFFs with 200 µM zaprinast. (C) Distribution of the maximum GCaMP 
signal. Fluorescence intensity was tracked following treatment with zaprinast and the time of the 
maximum signal over the entire PV was extracted. The histograms represent pooled data from four 
independent experiments, significance was tested by Wilcoxon log-rank. P < 0.05, - calcium. Data are 
pooled from 4 biological replicates each with evaluation of 76 – 153 PVs per experiment; N = 399. (D) 
Two representative traces showing the monophasic and biphasic classes of responding vacuoles. (E) 
Duration between the initiation and potentiation peaks in vacuoles that respond in a biphasic manner. 
Data shown are means ± s.e.m. from 3-4 biological replicates. (F) Egress kinetics among biphasic 
responding vacuoles. Pooled data from 4 independent experiments showing the percentage of 
egress over time in ranked order. 




As obligate intracellular pathogens, egress from the infected host cell is an 
absolute requirement for apicomplexan parasites. So it comes as no surprise these 
parasites have evolved a multitude of specialized effector molecules to complete this 
task. While currently only one such protein has been mechanistically described in 
Toxoplasma (PLP1) 10, 11, 39, there have been suggested roles for a genetically 



















































Figure 2-6. mCherry release from the PV in parasites lacking lcat. 
(A) Series of images showing the increase in GCaMP intensity (top row) and the accompanying 
loss of mCherry signal from the PV as the PVM is ruptured (bottom row). (B) One representative 
trace illustrating what a typical calcium response and mCherry loss looks like. (C) Quantification 
of mCherry release from the PV in relationship to calcium response. mCherry loss was defined as 
the time point of the greatest change in mCherry intensity within the PV (∆I), and was normalized 
to the time of maximum GCaMP intensity (Imax). Data are representative of 2 independent 
experiments, no significance in the median distribution was found by Wilcoxon log-rank test. 
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as an effector. Host calpain proteases have also been implicated, which are thought to 
facilitate egress by selective degradation of the host cytoskeleton prior to egress 8, 9. 
The landscape of secreted egress effectors has become somewhat better defined in the 
Plasmodium field, with roles being ascribed for secreted proteases such as SUB1, 
members of the SERA family, and DPAP3 15, 16, 56 in addition to several members of the 
perforin-like protein family  57-59. 
In 2005 a surface localized phospholipase, PbPL, was described in Plasmodium 
berghei, which facilitates sporozoite cell traversal 34, and was more recently shown to 
aid in merozoite egress from infected hepatocytes 52. Subsequently the Toxoplasma 
orthologue LCAT was shown to have a similar role in egress of tachyzoites in vitro 35. In 
a continuation of that study we have found a consistent role for LCAT in parasite 
egress, but were not able to identify a supporting role in parasite replication or a 
noticeable role in vivo. One possible explanation is the original LCAT knockout was 
made in the RH strain, which can exhibit off target integration of knockout constructs. 
Replication and virulence phenotypes in the original LCAT knockout were reversed; 
however, complementation was achieved by integration of multiple copies of the 
expression construct, resulting in marked overexpression of LCAT. We assessed 
replication and virulence in two independent knockouts, including one created in the 
RH∆ku80 background, which allows more precise disruption and complementation. We 
can not rule out that replication and virulence phenotypes in the new ∆lcat strains were 
blunted by compensatory changes in expression of other genes that dictate egress. 
However, a recent genome-wide mutagenesis screen revealed that parasites lacking 
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LCAT were not at a competitive disadvantage in culture 60, supporting the conclusion 
that LCAT does not contribute substantially to parasite replication. 
Work describing PbPL has shown an interesting observation of differential 
localization: sporozoites express PL on the surface, while in developing merozoites PL 
localizes to the PVM 34, 52. This differential localization is consistent with the role of 
PbPL in sporozoite disruption of the HPM during cell traversal and merozoite rupture of 
the PVM during egress from hepatocytes. Work from the Coppens lab has shown a 
similarly interesting dual localization: soluble within the PV during intracellular 
replication, and shifting to the parasite surface following egress 35. We attempted to 
visualize this apparent relocalization of LCAT, but were unable to do so because: (1) 
anti-HA antibodies failed to detect LCAT-HA by immunofluorescence staining in our 
hands and subsequently by an independent group 92; (2) our antibodies made to 
recombinant LCAT also did not work for immunofluorescence; and (3) LCAT 
endogenously tagged with a C-terminal YFP fusion showed an egress defect, 
suggesting that placement of a large tag at this location compromised LCAT function. 
Nevertheless, if LCAT redistribution occurs, several different scenarios can be 
envisioned for how LCAT contributes to calcium signaling and egress.  
In one scenario, LCAT phospholipase activity principally functions by disrupting 
host-derived membranes, namely the PVM and HPM, before associating with the 
parasite surface. LCAT disruption of the PVM and HPM could promote influx of calcium 
from the medium to help potentiate calcium signaling in the parasite. Indeed, calcium 
influx into Toxoplasma tachyzoites was recently shown to occur via an L-type calcium 
channel, resulting in enhanced calcium signaling, microneme secretion and gliding 
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motility 21. LCAT disruption of the PVM and HPM would also allow influx of serum 
components including serum albumin, which enhances parasite calcium signaling, 
microneme secretion, and gliding motility via activation of PKG 61. Supporting this role, 
we observed a trend toward ∆lcat parasites maintaining an intact PVM for a longer time 
period than wild type parasites relative to peak calcium signaling. Although additional 
data collection is needed to authenticate the trend, the findings tentatively suggest that 
LCAT is either directly able to rupture the PVM, or facilitate the activity of other factors 
to attack this membrane.  
In another scenario, LCAT could function on the parasite surface by generating 
products that enhance calcium signaling. LCAT phospholipase A2 activity generates 
lysophospholipids and fatty acids such as arachidonic acid (AA). In mammalian cells AA 
activates plasma membrane AA-regulated Ca2+ (ARC) entry channels, encoded by 
Orai2 and Orai3 proteins 62. Downstream metabolites of AA also activate certain plasma 
membrane transient potential channels including TRPV4 63. However, ARC and TRP 
channels are distinct from the aforementioned L-type calcium channel implicated in 
potentiation of calcium signaling in Toxoplasma via entry of environmental calcium. 
Additional studies are needed to distinguish the site of LCAT action and its precise role 
in potentiation of calcium signaling. Although our data do not definitively show that 
LCAT plays a role in calcium signaling due to variation between experiments, 
nevertheless there is a consistent trend showing a delay in calcium signaling in the 
strains lacking LCAT. One possible explanation for this is that between these 
experiments we purchased a different batch of zaprinast. The calcium signaling 
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phenotype was admittedly of modest strength, and the differences in zaprinast purity, 
concentration, etc. between the two batches may account for the altered results. 
Along these lines, LCAT is closely related to lysosomal-phospholipase A2 
(LPLA2), and the canonical LPLA2 lipase motif, AxSxG, is conserved. LPLA2 enzymes 
have been shown to become active at low pH 40, and it has been reported the PV 
acidifies prior to egress 39. Alternatively, the clue to regulation may lie in the proteolysis 
LCAT undergoes. Recently several members of the dense granule secretagogue have 
proven to be processed at PEXEL motifs in an aspartyl protease dependent manner. 
While it is true that many of these proteins contain the PEXEL signal in their N-terminal 
regions, LCAT does contain a PEXEL motif RRLEE starting at amino acid 594, and 
cleavage at this location would create proteolytic products of approximately the size 
seen in this study (Figure 2-1D). Cleavage of PEXEL containing motifs has been 
purported to drive localization to the PVM 64. 
Finally, it remains to be seen if a cooperative function exists between LCAT and 
other egress effectors, such as PLP1 and GRA41. As described by Hybiske and 
Stephens 36, many intracellular pathogens co-opt pore-forming toxins (PFT) and 
phospholipases to escape membrane entrapment. Also worth noting are the parallels 
we see in Plasmodium spp., with stage specific expression of different PFTs and stage 
specific activity of PbPL (sporozoite transmigration vs. merozoite egress). While in 
these systems a direct role has not been established for cooperativity between these 
two molecules, there are established examples of PFTs directly enhancing 
phospholipase activity, as is the case in bee venom 65. As for GRA41, a recent study 
showed that a mutation in this dense granule protein results in aberrations of parasite 
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calcium levels and egress. Parasites lacking GRA41 exhibit dysregulation of calcium ion 
uptake, leading to altered calcium ion homeostasis and premature egress 66. Although 
LCAT and GRA41 appear to affect egress in opposite ways, they both reside in the PV, 
suggesting an emerging role for PV resident proteins in Toxoplasma egress. 
 
2.4 Materials and Methods 
 
Ethics statement 
This study was carried out in strict accordance with the Public Health Service 
Policy on Humane Care and Use of Laboratory Animals and Association for the 
Assessment and Accreditation of Laboratory Animal Care guidelines. The animal 
protocol was approved by the University of Michigan’s Committee on the Use and Care 
of Animals (Animal Welfare Assurance #A3114-01, protocol #09482). All efforts were 
made to minimize pain and suffering of the mice. 
 
Parasite culture 
Toxoplasma tachyzoites were maintained by serial passaging and growth in human 
foreskin fibroblasts (HFF) cells. Cell cultures were grown in Dulbecco’s Modified Eagle 
Media (DMEM, source) supplemented with 10% fetal bovine serum (FBS, source), 2mM 
glutamine and 10 mM HEPES and grown in 5% CO2 at 37ºC. Parasites were liberated 
by scraping the infected HFF monolayer and passage through a 27G needle. The 
liberated parasites were then filtered through a 3 µm size filter (Millipore), counted on a 
hemocytometer, and added to HFFs at the appropriate density. For routine culture of 
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the parasites, 5 drops of naturally egressed parasites were passed into fresh host cells 
in a T25 flask. 
 
Creation of transgenic strains 
The knockout construct was constructed via fusion PCR. 5’ and 3’ homologous flanks 
were amplified from RH gDNA using ajsP1 + ajsP22 and ajsP6 + ajsP23, respectively. 
The dhfr selectable marker was amplified from pYFP.LIC.DHFR (Addgene) with ajsP20 
+ ajsP21. These three products were used as template and fused via a final PCR 
reaction with ajsP2 and ajsP5. The linear vector was transfected into RH∆ku80 
parasites and stable clones were isolated based on pyrimethamine resistance. The 
complement construct (pLCAT.Ku80.HXG) was created via Gibson cloning (In-Fusion, 
Clontech). The vector pM2AP.Ku80.HXG was prepared by double digestion with AscI + 
SpeI and purified by gel extraction (Qiagen). The 5’ and 3’ lcat flanking sequences were 
amplified from RH gDNA with primer pairs ajsP62 + ajsP52, and ajsP63 + ajsP59, 
respectively. The lcat cDNA was amplified from a cDNA library with primer pair ajsP53 + 
ajsP58. The catalytically dead construct, pLCATs332a.Ku80.HXG, was generated using 
site-directed mutagenesis (QuikChange XL, Agilent Technologies) and primers ajsP64 + 
ajsP65. The constructs were linearized prior to transfection by double digest with KpnI + 
ApaLI and transfected into RH∆ku80∆lcat parasites, and stable clones were isolated 
based on resistance to MPA + Xan. For creation of RH∆lcat lines using CRISPR-Cas9, 
20bp of lcat specific guide sequence was inserted into pCRISPR-Cas9-Ble, using site-
directed mutagenesis and the primer pair ajsP200 + ajsP201. PCR was used for genetic 
confirmation shown in Figure 2-1 as follows: amplification across exon1 & exon 2 (A)—
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ajsP15 + ajsP138; integration of the 5’ end of the complement construct at the ku80 
locus (B)—XhoI_Ku80_5\’Flank.f + ajsP138; integration of the 3’ end of the complement 
construct at the ku80 locus (C)—ajsP19 + XhoI_Ku80_5\’Flank.r. 
 
Plaque assay 
Infected monolayers in a T25 were washed 3X with 37ºC PBS prior to scraping and host 
lysis as described above. Parasite suspensions were made via serial 10-fold dilution to 
reach a concentration between 75 – 150 parasite / 150 µl PBS. Monolayers of HFFs in 
individual 6-well plates were immediately inoculated with 150 µl of the parasite solution. 
The infected monolayers were then incubated, undisturbed, for 7 days prior to fixation 
with 2% crystal violet. Plaques were quantified using ImageJ on wells that had been 
digitally scanned with an included ruler for setting the scale. 
 
Replication assay 
Infected HFFs were fixed with 4% paraformaldehyde at either 16 or 32 hours post 
infection. The fixed monolayers were permeabilized with 0.01% Triton X-100 and 
labeled with rabbit anti-SAG1 and counterstained with DAPI. At least 250 vacuoles were 
quantified per strain per experiment. 
 
Generation of LCAT specific polyclonal antibodies 
The bacterial expression construct pET15b was linearized with inverse PCR (iPCR) with 
primer pair ajsP142 + ajsP144. The lcat coding sequence was amplified with ajsP143 + 
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Groups of 5 female BALB/c or Swiss Webster (Jackson) female mice, aged 6 weeks, 
were infected with either 10 or 50 T. gondii tachyzoites subcutaneously in 150µl of PBS. 
Delivery of an accurate dose of infectious parasites was confirmed by performing 
plaque assays in parallel (described above). In the event of mice surviving the infection, 
seropositivity was tested by enzyme-linked immunosorbent assay (ELISA). 
 
In vitro competition assay 
RH∆lcat parasites were transfected with a GPI-anchored GFP variant and stable clones 
were selected following treatment with pyrimethamine. Extracellular parasites were 
counted on a hemocytometer and roughly equal numbers (5 x 105) of both RH and 
RH∆lcatGFP parasites were co-inoculated into a T25 of HFFs. Following lysis of the 
host cell monolayer extracellular parasite were collected, filtered, and fixed on poly-L 
lysine coated glass slides. Parasites were immunolabeled with rabbit anti SAG1, and 
enumerated via fluorescence microscopy. This process was repeated for a total of 3 
passages. 
 
Egress assay (LDH) 
30 h prior to assay, infected monolayers in a T25 were washed 3X with 37ºC PBS prior 
to scraping and host lysis as described above. Following centrifugation, parasites were 
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resuspended to a density of 5 X 105/ml and 100 µl were used per well (5 x 104 
tachyzoites). Prior to egress assays, infected wells were washed 3X with 37ºC Ringer’s 
buffer, after the final wash cells were treated with either 57 µM zaprinast diluted in 
Ringer’s, or Ringer’s solution with an equal volume of DMSO. The treated plates were 
allowed to incubate at 5% CO2 and 37ºC for 20’ before removal and immediate 
placement on ice. 50 µl of the supernatant was removed and placed into individual wells 
of a 96-well round bottom plate. The round bottom plates were centrifuged at 4ºC at 
500g, for 5 minutes. 30 µl of solution was removed and stored at 4ºC, and used within 1 
hour as source assay material for LDH content (BioVision). 
 
Calcium signaling 
All calcium signaling experiments utilized parasites expressing cytosolic GCaMP 
(courtesy of Silvia Moreno, University of Georgia). 30 h prior to assay, infected 
monolayers in a T25 were washed 3X with 37ºC PBS prior to scraping and host lysis as 
described above. 5 x 104 tachyzoites were added to confluent monolayers in an 8-well 
chamber slide (Ibidi), and allowed to replicate. To observe calcium signaling during 
induced egress, infected monolayers were washed 3X with 37ºC Ringer’s buffer, after 
the final wash 100 µl of Ringer’s buffer was added to each well. Imaging plates were 
placed in an environmental chamber heated to 37ºC on a Zeiss Axio inverted 
microscope equipped with an Axiocam MRM CCD camera using a 20X objective. 
Zaprinast was added at a 200 µM final concentration by adding 100 µl of a 400 µM 
solution in Ringer’s buffer. Acquisition was captured at a frame rate of 2-3s for 4 
minutes total.  
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mCherry Release 
For assays examining the integrity of the PVM, 5x107 purified RH and RH∆lcat parasites 
expressing cytosolic GCaMP were transfected with 50 µg of a plasmid expressing two 
copies of mCherry under the tubulin promoter (pTub mCherry_mCherry). Following 
transfection, 1x106 parasites were added to confluent HFF monolayers in glass bottom 
chamber slides (Ibidi), and allowed to replicate for 30 hours. Egress induction and 
image acquisition were identical to the calcium signaling assays previously described, 
with the following exceptions: 1) 2 µM cytochalasin D was included in the induction 
media to paralyze egressing tachyzoites, and 2) in addition to using a GFP filter cube, 
images were also collected using a Texas Red cube to observe the mCherry signal in 
the PV. 
  






LCAT processing and activity 
 
3.1 Introduction 
Within the Apicomplexan parasites, Plasmodium falciparum is the most infamous 
due to massive negative impact on human health—over 2 billion people are exposed to 
this parasite every year 67. One reason underlying these parasite’s ability to accomplish 
such a massive feat, is their capacity to interact with and modulate the infected host 
cell; a process mediated by secreted, exported proteins 68. In order for this process to 
occur, the parasite proteolytically processes secreted proteins to drive their interaction 
with the host cell 69. In Plasmodium spp. the details of this process that are best 
understood involve three aspects: 1) a Plasmodium export element (PEXEL), which is a 
pentapeptide motif of RxLxE/Q/D (x is any amino acid) that serves as a cleavage motif 
68, 70; 2) an aspartyl protease, Plasmepsin V that serves as a maturase by recognizing 
and cleaving PEXEL motifs 71; and 3) a translocon that exports cleaved PEXEL-
containing proteins across the PVM into the host cytosol 72, 73. Despite the close 
relationship between Toxoplasma and Plasmodium spp. a parallel process in T. gondii 
has remained elusive until recently. 
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Following host cell invasion by the Toxoplasma tachyzoites, the parasite resides 
within a parasitophorous vacuole (PV) that does not fuse with host cell membranes, 
including host lysosomes 74. Unlike protein secretion from the micronemes or the 
rhoptries, proteins from the dense granules (GRA proteins) are secreted post invasion 
while the parasite resides within the PV. While the functions of GRA proteins are quite 
diverse, they have traditionally been implicated in the establishment of the vacuole as a 
replicative niche 75. With the recent discovery of GRA protein processing, a novel role 
for dense granule proteins has been uncovered in host:parasite interactions. GRA15, 
16, and 24 have recently been reported to be processed and exported into the host cell 
where they alter host gene expression 76-78. Additionally, GRA19, 20, and 21 are 
processed but instead of export into the host cell they are subsequently targeted to the 
parasitophorous vacuolar membrane (PVM) 64. Furthermore, the processing and export 
of these GRA proteins primarily occurs through machinery that is homologous to those 
initially observed in Plasmodium spp. 64, 79-81. There is at least one alternative pathway 
for protein export and processing 78, but so far the significance between the two has not 
been uncovered. 
Along these lines, TgLCAT is among the subset of dense granule proteins that 
are proteolytically processed 35. The nature of this event remains uncharacterized, 
however the predicted cleavage site based off the size of the processed fragments, is 
located near a PEXEL motif and falls within a unique domain. LCAT contains an 
approximately 140 amino acid inserted element (465 – 605) within the conserved 
catalytic PLA2 domain, this insert is not conserved in other members of the Apicomplexa 
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phylum—and is only seen within the coccidian subgroup as all other homologues 
encode intact domains.  
TgLCAT is predicted to be a member of the PLA2 family, which consist of a 
group of enzymes that are unrelated in their structure and vary in their mechanisms of 
lipid hydrolysis, but share the common function of sn-2 hydrolysis of the central carbon 
of phospholipids 93. This group is diverse and contains secreted PLA2s, cytosolic PLA2, 
and lysosomal phospholipase A2, among others. One of the common features shared 
among these molecules and TgLCAT is the presence of an alpha/beta hydrolase fold 
and a Ser/His/Asp catalytic triad. The alpha/beta hydrolase fold is characterized by a 
central beta sheet of 7 parallel strands interspersed with alpha helices on both sides 94. 
The catalytic mechanism of these enzymes is similar to that of trypsin, despite the lack 
of similarity in sequence and function between the two. Substrate binding positions the 
oxygen of the carbonyl group in the oxyanion hole, then a charge-relay system through 
the catalytic triad activates the oxygen atom of the catalytic serine that is responsible for 
nucleophilic attack. The histidine residue then protonates the leaving group, with the H+ 
ion from nucleophilic attack 95. 
Outside of the conserved alpha/beta hydrolase fold, TgLCAT shares another 
common feature of PLA2 enzymes, the cap domain. The cap domain is found above the 
catalytic site, and blocks access in the absence of a substrate. One common feature of 
all lipases is their activity at the lipid/water interface, and in PLA2 enzymes with cap 
domains, binding to a target membrane generally induces a conformational change that 
allows substrate access by removal of the cap blockage 96. Little is known specifically 
about the activation of LPLA2 enzymes, but many lipases are activated by a 
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phenomenon known as “interfacial activation” which occurs when an enzymes binds to 
a lipid membrane—and many lipases are more active when substrates are presented in 
the form of liposomes or micelles 97. One thought for how this may occur is that in 
enzymes that possess a mobile “lid” element, binding to a lipid interface displaces the 
lid element and exposes hydrophobic elements of the enzyme that further drive 
association of the protein with target membranes 98,99. 
In this study we attempt to explore the aspects involved in TgLCAT processing 
and the biochemical nature underlying them. 
 
3.2 Results 
3.2.1 LCAT structure and phylogeny 
The LCAT ORF is located on chromosome VII of T. gondii, and codes for a 
protein of 763 amino acids in length. The protein has a conserved phospholipase A2 
(PLA2) domain, and this domain shares a high degree of homology for two types of 
PLA2: lysosomal phospholipase A2 and lecithin cholesterol acyltransferase (34% vs. 
31% respective homology with H. sapiens). TgLCAT contains a conserved pentapeptide 
motif, AHSLG, that is characteristic of serine lipases (Figure 3-1A). The serine residue 
of this motif forms the acylated center of the catalytic triad (SDH; 
serine/aspartate/histidine), and these residues are found across the phylum. TgLCAT is 
well conserved within the Apicomplexan’s, with the coccidian members of the phylum 
forming a subgroup (Figure 3-1B). This sub group is likely due to the presence of an 
inserted domain at positions 465-605, which is only seen among the coccidians. This 
insert effectively splits the conserved PLA2 domain of TgLCAT into two entities. In 
addition to these features, TgLCAT also contains a signal peptide that targets the 
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protein to the parasite’s secretory pathway, and an N-terminal domain that shares no 
homology with known proteins (Figure 3-1C). 
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3.2.2 LCAT is processed  
 
LCAT is expressed by the tachyzoites and is readily detected by SDS-PAGE and 
western blotting; surprisingly, LCAT is not detected as a whole fragment but is instead 
FIGURE 2. TgLCAT expression and secretion by T. gondii. A, transcriptional profiles of lcat in tachyzoites (Tz), bradyzoites (Bz), partially sporulated oocysts
(Ooc), and sporozoites (Spz). Expressionof lcat transcripts fromall parasite stageswas assayedbyRT-PCR. Toverify theabsenceofgenomicDNAcontamination,
RT-PCRs were set up in duplicate with (!) and without (") reverse transcriptase (RT). B, expression of TgLCAT. Immunoblots on parasite lysates separated by
SDS-PAGE and probed with anti-TgLCAT antibodies reveal two bands, one corresponding to the predicted size of TgLCAT (double arrow) and the other one
corresponding to cleaved product of the protein. No signal on immunoblots was observed on these lysates probed with preimmune serum. C, secretion of
TgLCAT. Panel a, immunoblots on lysates of transgenic parasites expressing LCAT-HA separated by SDS-PAGE and probed with either anti-TgLCAT or anti-HA
antibodies show two forms of TgLCAT products with different sizes of peptides (single arrows) and TgLCAT full-length (double arrow). Panel b, immunoblots of
lysates of transgenic parasites expressing LCAT-HA after intracellular cross-linking of TgLCAT fragments usingDSP, separation by SDS-PAGE, and probingwith
anti-HA antibodies show full-length TgLCAT (double arrow) and an upper band at 105 kDa absent from lysates under control conditions (DMSO). Panel c,
immunoblots of material secreted by transgenic parasites expressing LCAT-HA separated by SDS-PAGE and probedwith anti-TgLCAT and anti-HA antibodies
show stronger bands corresponding to LCAT fragments compared with a weaker band for full-length protein (double arrow). Parasite-secreted material was
also probedwith antibodies against GRA7 (positive control) and against SAG1 (control for parasite cell integrity).D, schematic illustration of TgLCAT. Predicted
domain structure of TgLCAT is shownwith putative signal peptide (SP), membrane-binding domain (MBD) based on homologywith human LPLA2, N-terminal
catalytic fragment (N-term cat. frag.), cap domain (Cap), inserted element (IE), and C-terminal catalytic fragment (C-term). Numbers above the illustration
indicate amino acid position at the b ginning of select dom ins. Position of the recombinant polypeptide used to immunize rats for anti-TgLCAT (!-TgLCAT)
is indicated. Positions of catalytic residues SDHare indicatedwith red spheres. A putative coiled-coil domainwithin the inserted element is shownbased on the
highest scoring ab initio model from I-TASSER. The precursor TgLCAT species and putative proteolytic fragments are indicated as black lines below the
schematic,withdashed lines indicating theestimated regionofproteolysis. E, structuralmodel of TgLCAT.Modelwas constructedwithPhyre2,which identified
humanLPLA2 (ProteinDataBankcode4X91) as thehighest scoring template for threading.Domains are coloredaccording to thepublished structureofhuman
LPLA2 (34). The position of the inserted element is indicated with an arrow, with the two flanking amino acid backbone residues shown in cyan. Catalytic
residues, including their side changes, are shown as spheres and labeled with the single letter designations for the corresponding amino acids. The image on
the right is viewed from the perspective of the membrane, with the catalytic pocket shown centrally. The left image is rotated 90° from the right image.
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TgLCAT          MDFLSGGRKGRVCAKRFRLSPILWFASALVLIPLGCSPFKTDVALSSPFSPYRPSIHSAS    60 
PbLCAT          ------------------------------------------------------------ 
HsLCAT          ------------------------------------------------------------ 
                                                                             
 
TgLCAT          TSASAQEPPASVHPTPSAVPSDPQVASRVGPHGATKSGFSRATRENVPAFPSRDPSFSTS   120 
PbLCAT          ------------------------------------------------------------ 
HsLCAT          ----------------------------------------------------------MG     
                                                                             
       
TgLCAT          VPSSTVSETDSGIFVVSSQDPVANQDHGISSVPSTASEPDSGVDHALFVIPGIAGSGLFA   180 
PbLCAT          ------------------------MEIVGSSKRSNSAISDKKIKNSVYLIPGLGGSTLIA 
HsLCAT          PPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEA 
                                              .  :..    .   ..: ::**  *. * * 
 
TgLCAT          TVTNASVASCGKSPISYPNPFRVWASLSLLLPPATHQKCWIDMMKMVVDENGEVYTGQEG   240 
PbLCAT          EYNDADIESCS-SKLLHSKPYRIWLSISRFS-IRSNVYCLFDTLKLDYDRENKIYRNKPG 
HsLCAT          KLDKPDVVNWMCYRKTED-FFTIWLDLNMFL--PLGVDCWIDNTRVVYNRSSGLVSNAPG 
                   ...: .           : :* .:. :        * :*  ::  :... :  .  * 
 
TgLCAT          VRVEVDGYGGIHAIDYLDYYMNNTYGVPASAYMHVMLRTLMSLHYSQFVTLRGVPYDWRL   300 
PbLCAT          VIINVENYGYIKGVAFLDYVKN--KPLRLTRYYGILADKFLENEYIDGKDILSAPYDWRF 
HsLCAT          VQIRVPGFGKTYSVEYLD-------SSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRL 
                * :.* .:*   .: :**           : *   :  .::.  *     : ..*****: 
 
TgLCAT          PPWQLD--YAQLKTDIEDRYTEMNNRKVDLIAHSLGSIILCYFLNRIVDQAWKDKYIGSM   358  
PbLCAT          PLSQQK--YNVLKSHIEHIYKIKQEIKVNLIGHSLGGLFINYFLSQFVDEEWKKKHINIV 
HsLCAT          EPGQQEEYYRKLAGLVEEMHAAYG-KPVFLIGHSLGCLHLLYFLLRQP-QAWKDRFIDGF 
                   * .  *  *   :*. :       * **.**** : : *** :   : **.:.*. . 
            
TgLCAT          TIVAAATGGSFKAIKSLLSGYDDATDVDIWNVIDISLFPAGLLRDLLQTMGSIFALLPDP   418 
PbLCAT          IHINVPFAGSIKAIRALLYNNKDYTLFKLKNILKVSISGS-LMRAISHNMGSPLDLLPYR 
HsLCAT          ISLGAPWGGSIKPMLVLASGDN----QGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPED 
                  : .. .**:*.:  *  . .      :  : .:.:     :      * .     *   
 
TgLCAT          AIYGPDHVVARVARPTQVPASSSASAFAPLTGRSDRAAKKAEGTTSTALRWSHSGEMRRL   478 
PbLCAT          KYYDRDQIVVIIN----------------------------------------------- 
HsLCAT          HVFISTP----------------------------------------------------- 
                  :                                                          
 
TgLCAT          DAVLTDEVGGPESGARELKSEQAFSLLSELAKDNVEVEKEEAEGETNTRFHKYPDFAPGD   538 
PbLCAT          ------------------------------------------------------------ 
HsLCAT          ------------------------------------------------------------ 
                                                                             
 
TgLCAT          QMEEEELAKAEERRDALLREFQLQNRLSHEDRAARQRERYSLFVEKEQRRLDEALRVAQE   598 
PbLCAT          ---MDEFPIDEKLAQSIVTECGIYNESCYTDRED-------------------------- 
HsLCAT          -----SFNYTGRDFQR-------------------------------------------- 
                     .:    .  :                                              
 
TgLCAT          QRLEEDVYTLSNWTSLLPANLQRRVK-TAQEKMAGVVADPGVPVRCIWSKFSQPTTDVAY   658 
PbLCAT          --VNLKTYTLSNWYELLSNDMREKYENYIQYTDRFFSVDHGIPTYCLYSTTKKKNTEYML 
HsLCAT          --FFADLHFEEGWYMWLQS-----------RDLLAGLPAPGVEVYCLYGVG-LPTPRTYI 
                  .  . :  ..*   *                       *: . *::.     ..     
 
TgLCAT          YYPTGSLDTHPIRIFDYGDNTVPLASLSLCASWPSTVQTKVFDNLDHMFLFADRGFNNFI   718 
PbLCAT          FYQDTHFIQDPIIYYGIGDGTIPLESLEACKKLQNVKEAKHFEYYKHIGILKNDIVSDYI 
HsLCAT          YDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLT 
                :             :  **.*:.  * . *    .      .    *     :  ..:   
 
TgLCAT          FDIFSPDANPFLSSLLGEQEEVMKRDIPSPQESVPAGRGAIMADST   764 
PbLCAT          YNIIDKNTTN------------------------------------ 
HsLCAT          LEHINAILLGAYRQGPPASPTASPEPPPPE---------------- 


























































FIGURE 1. Comparison of sequences of the predicted ORF of LCAT from T. gondii and other organisms andmolecular phylogeny of LCAT proteins. A,
alignment of the primary sequences of TgLCAT, P. berghei LCAT (PbLCAT; PBANKA_112810), and human LCAT (HsLCAT; AAB34898.1). Identical amino acids are
indicated by asterisks. The conserved (G/A)XSXG pentapeptide sequence of the serine lipase family is boxed; the carboxyesterase active-site serine motifs and
cysteine residues for potential disulfide linkages arehighlighted in yellow andgreen, respectively; the lid region is shown inblue; potential hydrophobic regions
are indicated in brown; N-linked glycosylation sites are in red; and N-myristoylation site is in green. B, sequence relationships among LCAT family proteins.
Unrooted phylogenetic tree of the LCAT family proteins constructed using neighbor joining analysis.Numbers at the branch nodes represent bootstrap values
(as percentages) obtained in 1,000 replications. Branch lengths indicate the number of amino acid differences.
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FIGURE 1. Comparison of sequences of the predicted ORF of LCAT from T. gondii and other organisms andmolecular phylogeny of LCAT proteins. A,
alignment of the primary sequences of TgLCAT, P. berghei LCAT (PbLCAT; PBANKA_112810), and human LCAT (HsLCAT; AAB34898.1). Identical amino acids are
indicated by asterisks. The conserved (G/A)XSXG pentapeptide sequence of the serine lipase family is boxed; the carboxyesterase active-site serine motifs and
cysteine residues for potential disulfide linkages arehighlighted in yellow andgreen, respectively; the lid region is shown inblue; potential hydro hobic regions
are indicated in brown; N-linked glycosylation sites are in red; and N-myristoylation site is in green. B, sequence relationships among LCAT family proteins.
Unrooted phylogenetic tree of the LCAT family proteins constructed using neighbor joining analysis.Numbers at the branch nodes represent bootstrap values
(as percentages) obtained in 1,000 replications. Branch lengths indicate the number of amino acid differences.
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Figure 3-1. Phylogeny and schematic of TgLCAT.  
(A) Multiple sequence alignment of the conserved lipase domain of TgLCAT homologues, species 
shown: Toxoplasma gondii, Plasmodium berghei, Homo sa iens. (B) sequence relationships 
among LCAT family proteins. Unrooted phylogenetic tree of the LCAT family proteins constructed 
using neighbor joining analysis. Numbers at the branch node  represent bootstrap values (as 
percentages) obtained in 1,000 replications. Branch lengths indicate the number of amino acid 
differences. (C) schematic illustration of TgLCAT. Predicted domain structure of TgLCAT is shown 
with putative signal peptide (SP), membrane-binding domain (MBD) based on homology with 
human LPLA2, N-terminal catalytic fragment (N-term cat. frag.), cap domain (Cap), inserted 
element (IE), and C-terminal catalytic fragment (C-term). Numbers bove the illustration indicate 
a ino acid position at the beginning of select domains. Position of the recombinant polypeptide 
used to immuniz  rats for anti-Tg AT ( -TgLCAT) is indicated. Positions of catalytic residues SDH 
are indicated with red spheres. A putative coiled-coil domain within the inserted element is shown 
based  the hi h st scoring ab initio model from I-TASSER. he pre u sor TgLCAT species a d 
putative roteolytic fragments are indicat d as bl ck lines b low the sche atic, with d shed lin s 
indicating the estimated region of proteolysis.  
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seen as two distinct species: a full-length and a processed form—the result of 
proteolytic cleavage of the protein  (Figure 2-1). Immunoblots of parasite lysates reveal 
a full-length band of ~105 kDa, and a smaller band ~38 kDa which represents the 
processed C-terminal fragment. Interesting the size of the observed full length product 
differs from the predicted size (~83 kDa). 
We next sought to determine if the processing of LCAT would destroy the 
enzyme’s ability to function, and to aid in our understanding and visualization of this 
aspect we attempted to model the tertiary structure of TgLCAT. The modeling was done 
using the recently solved Homo sapiens LPLA2 structure as a template 91, which was a 
higher scoring computational template for threading than HsLCAT. The predicted model 
of TgLCAT shows the formation of an active site with residues that would remain in 
close proximity to one another based on folding of the core catalytic domain, and the 
presence of disulfide bridges spanning both fragments of the protein that would 
effectively pin the enzyme together following cleavage (Figure 3-2). The location of the 
inserted element maps to a conserved cap region, which based on predictions would be 
unlikely to interfere with substrate access. TgLCAT contains two predicted PEXEL 
motifs RDLLQ at position 402 and RRLEE at position 587, and cleavage near position 
587 would roughly account for the size of the processed fragments. Additionally, when 
intracellular parasites were treated with DSP, a cell-permeant cross linker, LCAT 
migrated as a single species when detected by western blot 35, indicating that even after 
cleavage the two LCAT fragments remain in close proximity, likely as a non-covalent 
complex. 
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3.2.3 LCAT is not processed in extracellular parasites 
 
In order to gain more insight into the processing event and to further characterize 
the role that processing plays in the secretion and activity of TgLCAT, we generated 
mouse polyclonal antibodies against the secreted form of the protein (residues 39-763). 
Thirteen BALB/c mice were immunized and thereafter boosted with recombinant 
TgLCAT, and were then tested by ELISA for LCAT affinity (Figure 3-3A). The sera 
showing the highest affinity for the recombinant protein were pooled and then tested for 
specificity via western blotting on wild-type and ∆lcat parasite lysates. Initial blots with 
the polyclonal antibody showed a high degree of non-specific background staining, 
which was significantly reduced following affinity purification of the pooled sera (Figure 
3-3B). Unfortunately, we were still only able to detect the full-length and the C-terminal  
 
FIGURE 2. TgLCAT expression and secretion by T. gondii. A, transcriptional profiles of lcat in tachyzoites (Tz), bradyzoites (Bz), partially sporulated oocysts
(Ooc), and sporozoites (Spz). Expressionof lcat transcripts fromall parasite stageswas assayedbyRT-PCR. Toverify theabsenceofgenomicDNAcontamination,
RT-PCRs were set up in duplicate with (!) and without (") reverse transcriptase (RT). B, expression of TgLCAT. Immunoblots on parasite lysates separated by
SDS-PAGE and probed with anti-TgLCAT antibodies reveal two bands, one corresponding to the predicted size of TgLCAT (double arrow) and the other one
corresponding to cleaved product of the protein. No signal on immunoblots was observed on these lysates probed with preimmune serum. C, secretion of
TgLCAT. Panel a, immunoblots on lysates of transgenic parasites expressing LCAT-HA separated by SDS-PAGE and probed with either anti-TgLCAT or anti-HA
antibodies show two forms of TgLCAT products with different sizes of peptides (single arrows) and TgLCAT full-length (double arrow). Panel b, immunoblots of
lysates of transgenic parasites expressing LCAT-HA after intracellular cross-linking of TgLCAT fragments usingDSP, separation by SDS-PAGE, and probingwith
anti-HA antibodies show full-length TgLCAT (double arrow) and an upper band at 105 kDa absent from lysates under control conditions (DMSO). Panel c,
immunoblots of material secreted by transgenic parasites expressing LCAT-HA separated by SDS-PAGE and probedwith anti-TgLCAT and anti-HA antibodies
show stronger bands corresponding to LCAT fragments compared with a weaker band for full-length protein (double arrow). Parasite-secreted material was
also probedwith antibodies against GRA7 (positive control) and against SAG1 (control for parasite cell integrity).D, schematic illustration of TgLCAT. Predicted
domain structure of TgLCAT is shownwith putative signal peptide (SP), membrane-binding domain (MBD) based on homologywith human LPLA2, N-terminal
catalytic fragment (N-term cat. frag.), cap domain (Cap), inserted element (IE), and C-terminal catalytic fragment (C-term). Numbers above the illustration
indicate amino acid position at the beginning of select domains. Position of the recombinant polypeptide used to immunize rats for anti-TgLCAT (!-TgLCAT)
is indicated. Positions of catalytic residues SDHare indicatedwith red spheres. A putative coiled-coil domainwithin the inserted element is shownbased on the
highest scoring ab initio model from I-TASSER. The precursor TgLCAT species and putative proteolytic fragments are indicated as black lines below the
schematic,withdashed lines indicating theestimated regionofproteolysis. E, structuralmodel of TgLCAT.Modelwas constructedwithPhyre2,which identified
humanLPLA2 (ProteinDataBankcode4X91) as thehighest scoring template for threading.Domains are coloredaccording to thepublished structureofhuman
LPLA2 (34). The position of the inserted element is indicated with an arrow, with the two flanking amino acid backbone residues shown in cyan. Catalytic
residues, including their side changes, are shown as spheres and labeled with the single letter designations for the corresponding amino acids. The image on
the right is viewed from the perspective of the membrane, with the catalytic pocket shown centrally. The left image is rotated 90° from the right image.
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TgLCAT          MDFLSGGRKGRVCAKRFRLSPILWFASALVLIPLGCSPFKTDVALSSPFSPYRPSIHSAS    60 
PbLCAT          ------------------------------------------------------------ 
HsLCAT          ------------------------------------------------------------ 
                                                                             
 
TgLCAT          TSASAQEPPASVHPTPSAVPSDPQVASRVGPHGATKSGFSRATRENVPAFPSRDPSFSTS   120 
PbLCAT          ------------------------------------------------------------ 
HsLCAT          ----------------------------------------------------------MG     
                                                                             
       
TgLCAT          VPSSTVSETDSGIFVVSSQDPVANQDHGISSVPSTASEPDSGVDHALFVIPGIAGSGLFA   180 
PbLCAT          ------------------------MEIVGSSKRSNSAISDKKIKNSVYLIPGLGGSTLIA 
HsLCAT          PPGSPWQWVTLLLGLLLPPAAPFWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEA 
                                              .  :..    .   ..: ::**  *. * * 
 
TgLCAT          TVTNASVASCGKSPISYPNPFRVWASLSLLLPPATHQKCWIDMMKMVVDENGEVYTGQEG   240 
PbLCAT          EYNDADIESCS-SKLLHSKPYRIWLSISRFS-IRSNVYCLFDTLKLDYDRENKIYRNKPG 
HsLCAT          KLDKPDVVNWMCYRKTED-FFTIWLDLNMFL--PLGVDCWIDNTRVVYNRSSGLVSNAPG 
                   ...: .           : :* .:. :        * :*  ::  :... :  .  * 
 
TgLCAT          VRVEVDGYGGIHAIDYLDYYMNNTYGVPASAYMHVMLRTLMSLHYSQFVTLRGVPYDWRL   300 
PbLCAT          VIINVENYGYIKGVAFLDYVKN--KPLRLTRYYGILADKFLENEYIDGKDILSAPYDWRF 
HsLCAT          VQIRVPGFGKTYSVEYLD-------SSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRL 
                * :.* .:*   .: :**           : *   :  .::.  *     : ..*****: 
 
TgLCAT          PPWQLD--YAQLKTDIEDRYTEMNNRKVDLIAHSLGSIILCYFLNRIVDQAWKDKYIGSM   358  
PbLCAT          PLSQQK--YNVLKSHIEHIYKIKQEIKVNLIGHSLGGLFINYFLSQFVDEEWKKKHINIV 
HsLCAT          EPGQQEEYYRKLAGLVEEMHAAYG-KPVFLIGHSLGCLHLLYFLLRQP-QAWKDRFIDGF 
                   * .  *  *   :*. :       * **.**** : : *** :   : **.:.*. . 
            
TgLCAT          TIVAAATGGSFKAIKSLLSGYDDATDVDIWNVIDISLFPAGLLRDLLQTMGSIFALLPDP   418 
PbLCAT          IHINVPFAGSIKAIRALLYNNKDYTLFKLKNILKVSISGS-LMRAISHNMGSPLDLLPYR 
HsLCAT          ISLGAPWGGSIKPMLVLASGDN----QGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPED 
                  : .. .**:*.:  *  . .      :  : .:.:     :      * .     *   
 
TgLCAT          AIYGPDHVVARVARPTQVPASSSASAFAPLTGRSDRAAKKAEGTTSTALRWSHSGEMRRL   478 
PbLCAT          KYYDRDQIVVIIN----------------------------------------------- 
HsLCAT          HVFISTP----------------------------------------------------- 
                  :                                                          
 
TgLCAT          DAVLTDEVGGPESGARELKSEQAFSLLSELAKDNVEVEKEEAEGETNTRFHKYPDFAPGD   538 
PbLCAT          ------------------------------------------------------------ 
HsLCAT          ------------------------------------------------------------ 
                                                                             
 
TgLCAT          QMEEEELAKAEERRDALLREFQLQNRLSHEDRAARQRERYSLFVEKEQRRLDEALRVAQE   598 
PbLCAT          ---MDEFPIDEKLAQSIVTECGIYNESCYTDRED-------------------------- 
HsLCAT          -----SFNYTGRDFQR-------------------------------------------- 
                     .:    .  :                                              
 
TgLCAT          QRLEEDVYTLSNWTSLLPANLQRRVK-TAQEKMAGVVADPGVPVRCIWSKFSQPTTDVAY   658 
PbLCAT          --VNLKTYTLSNWYELLSNDMREKYENYIQYTDRFFSVDHGIPTYCLYSTTKKKNTEYML 
HsLCAT          --FFADLHFEEGWYMWLQS-----------RDLLAGLPAPGVEVYCLYGVG-LPTPRTYI 
                  .  . :  ..*   *                       *: . *::.     ..     
 
TgLCAT          YYPTGSLDTHPIRIFDYGDNTVPLASLSLCASWPSTVQTKVFDNLDHMFLFADRGFNNFI   718 
PbLCAT          FYQDTHFIQDPIIYYGIGDGTIPLESLEACKKLQNVKEAKHFEYYKHIGILKNDIVSDYI 
HsLCAT          YDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLT 
                :             :  **.*:.  * . *    .      .    *     :  ..:   
 
TgLCAT          FDIFSPDANPFLSSLLGEQEEVMKRDIPSPQESVPAGRGAIMADST   764 
PbLCAT          YNIIDKNTTN------------------------------------ 
HsLCAT          LEHINAILLGAYRQGPPASPTASPEPPPPE---------------- 


























































FIGURE 1. Comparison of sequences of the predicted ORF of LCAT from T. gondii and other organisms andmolecular phylogeny of LCAT proteins. A,
alignment of the primary sequences of TgLCAT, P. berghei LCAT (PbLCAT; PBANKA_112810), and human LCAT (HsLCAT; AAB34898.1). Identical amino acids are
indicated by asterisks. The conserved (G/A)XSXG pentapeptide sequence of the serine lipase family is boxed; the carboxyesterase active-site serine motifs and
cysteine residues for potential disulfide linkages arehighlighted in yellow andgreen, respectively; the lid region is shown inblue; potential hydrophobic regions
are indicated in brown; N-linked glycosylation sites are in red; and N-myristoylation site is in green. B, sequence relationships among LCAT family proteins.
Unrooted phylogenetic tree of the LCAT family proteins constructed using neighbor joining analysis.Numbers at the branch nodes represent bootstrap values
(as percentages) obtained in 1,000 replications. Branch lengths indicate the number of amino acid differences.
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FIGURE 1. Comparison of sequences of the predicted ORF of LCAT from T. gondii and other organisms andmolecular phylogeny of LCAT proteins. A,
alignment of the primary sequences of TgLCAT, P. berghei LCAT (PbLCAT; PBANKA_112810), and human LCAT (HsLCAT; AAB34898.1). Identical amino acids are
indicated by asterisks. The conserved (G/A)XSXG pentapeptide sequence of the serine lipase family is boxed; the carboxyesterase active-site serine motifs and
cysteine residues for potential disulfide linkages arehighlighted in yellow andgreen, respectively; the lid region is shown inblue; potential hydro hobic regions
are indicated in brown; N-linked glycosylation sites are in red; and N-myristoylation site is in green. B, sequence relationships among LCAT family proteins.
Unrooted phylogenetic tree of the LCAT family proteins constructed using neighbor joining analysis.Numbers at the branch nodes represent bootstrap values
(as percentages) obtained in 1,000 replications. Branch lengths indicate the number of amino acid differences.
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Figure 3-2. Structural model of TgLCAT. Model was constructed with Phyre2, which identified 
human LPLA2 (Protein Data Bank code 4X91) as the highest scoring template for threading. 
Domains are colored according to the published structure of hu an LPLA2 (34). The position of 
the insert d element is ind ated with a  arrow, with the two flanking amino acid backbone 
residues shown in cyan. Catalytic residues, including their side changes, are shown as spheres 
and labeled with t e single lett r designations for th  corresponding amino acids. The image on 
the right is viewed from the perspective of the membrane, with the catalytic pocket shown 
centrally. The left image is rotated 90° from the right image.  
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Figure 3-3. TgLCAT is not processed in 
extracellular parasites. 
(A) Serum ELISA from 13 mice immunized 
with recombinant LCAT39-763. (B) Western 
blot on pooled sera before and after affinity 
purification, note size shift due to presence 
of HA epitope tag. (C) Pulse chase 
experiment showing that TgLCAT is not 
processed. Lysates from wt and LCATHA 
parasites were immunoprecipitated with 
anti-HA antibodies. Arrow denotes full-
length protein and arrowhead is the 
predicted size of the cleaved product (~38 
kDa). Controls show appropriate maturate 
of M2AP and co-precipitation with MIC2. 
GRA4 shows an unprocessed dense 
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product via western blot, as the larger N-terminal fragment remained elusive. 
Furthermore, this antibody proved to be insufficient for immuno-staining, as indirect 
immunofluorescence assays against the wild-type and ∆lcat infected monolayers 
showed no specific staining. 
Next we sought to determine the spatial and temporal aspects that govern 
TgLCAT processing by examining this process in close detail using radio-labeling and 
pulse chase experiments. After a 15 minute metabolic labeling with 
[35S]methionine/cysteine, samples were collected every 15 minutes, followed by LCAT 
immunoprecipitation using HA antibodies. Surprisingly, these experiments revealed that 
LCAT is not processed while in intracellular parasites in the first 60 minutes following 
protein synthesis (Figure 3-3C).  
 
3.2.4 LCAT transacylase activity 
Our final attempts to characterize TgLCAT involved expression of the protein 
recombinantly for biochemical analysis. We chose to clone the secreted form of the 
protein (39-763) into a baculoviurs expression vector suitable for driving expression 
from insect cells, based off previous reports for this protein. This approach generated an 
extrememly limited amount of recombinant protein that displayed some activity. Initial 
experiments assayed transfer of radiolabeled phospholipid to ceramide (Figure 3-4A,B 
LPLA2 activity), and were positive for activity with the wild-type version of TgLCAT but 
not with a catalytically inert form of the enzyme (Figure 3-4C,D). However, due to 
limitations from the low amount of protein and issues with protein stability, these results 
could not be followed up on or reproduced. 
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Figure 3-4. LCAT transacylation activity. 
(A) Schematic illustrating the hydrolytic activity of LPLA2 in the absence of an 
acceptor molecule. (B) Schematic illustration the transacylation reaction of 
LPLA2 in the presence of the acceptor ceramide molecule. (C) Gel showing the 
transacylation driven by TgLCAT. DOPC/sulfatide/NAS liposomes (10/3/1 molar 
ratio) were used and incubated with cell homogenate (LPLA2) or purified protein 
for 60 minutes at 37ºC. The HPTLC plates were developed in a solvent  of 
chloroform:acetic acid (90/10 v/v). Ceramide (18-Avanti) standards were used to 
calculate LPLA2 activity. LPLA2 = human cell lysate; TgLCAT = wild type ; 
TgLCATdead = catalytically inactive mutant. FFA = free fatty acid; 1-O-Acyl 
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3.3 Discussion 
Microbial PLA2 enzymes have long been recognized for their contributions to 
pathogenesis and cytotoxicity. Here we have examined a recently discovered parasitic 
PLA2 that contains novel characteristics regarding its structure and maturation. TgLCAT 
is highly similar to both LPLA2 and LCAT enzymes, and more work is needed to 
definitively characterize the activity of this molecule. The conserved lipase domain, 
AHSLG present in TgLCAT is more predictive of LPLA2 enzymes than of LCAT 
enzymes 82, and we have generated limited data that supports this case as we have 
observed catalytically dependent transferase activity to ceramide. It is important to 
recognize however that this data was not thoroughly replicated due to conditions that 
we were unable to circumvent. Existing published data shows that TgLCAT has 
transferase activity to cholesterol 35; however in the original study transferase activity 
specific to ceramide was not tested. To date there have been no descriptions of PLA2 
enzymes that exhibit a dual transferase activity to both ceramide and cholesterol, but 
given the existing data this enzyme may be capable of catalyzing both reactions. 
TgLCAT is unique in that it belongs to a subclass of PLA2 enzymes that are oddly split 
by the insertion of a 140 amino acid insert that interrupts the conserved phospholipase 
domain. This insert is only conserved among the coccidians, and may hold the clues 
necessary for determining key differences between the homologues in terms of their 
localization (surface vs. secreted) and the processing observed in Toxoplasma. 
The processing itself is an interesting event, as recent data from several different 
groups have uncovered a pathway for dense granule processing that involves a PEXEL 
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cleavage signal, 64, and a maturase, ASP5 78-80. Interestingly, TgLCAT contains a 
PEXEL domain, RRLEE at position 587. Recent work has described PEXEL motifs 
starting with “RRL” residues as preferential signals for ASP5-mediated proteolysis 79, 
and consistent with this observation, LCAT has recently been reported to be processed 
by ASP5 at a non-canonical RRLxx motif at position 476. This was discovered in a 
proteomic screen identifying and sequencing the N-terminus of processed proteins 92.  
The more interesting question regarding LCAT processing is what affect this has on 
activity. The only Apicomplexan homolog to TgLCAT that has been studied is the 
Plasmodium berghei PbPL. Outside of the unique inserted element, these two 
homologs are closely conserved, yet PbPL is active without a cleavage event 34, and 
TgLCAT is apparently active while it is cleaved or uncleaved 35. Cleavage of the enzyme 
may simply target the protein to the PVM/IVN as previously proposed 64. The inserted 
element lacks homology to any known proteins; however, in situ modeling of this 
peptide using iTasser software (University of Michigan) predicts the formation of a 
coiled coil domain. As the RRLx PEXEL motif lies just at the edge of this domain (insert: 
465-605; RRLxx: 467), cleavage at this location may release the coiled-coil and provide 
steric freedom to drive protein:protein interactions or correctly position the enzyme 83. 
Alternatively, we need to consider that there exists a possibility that TgLCAT is 
not cleaved at all, or is only cleaved while the parasites are intracellular. Following 
metabolically labeled protein over the course of 1 hour, we were not able to detect 
cleavage in extracelluar parasites. While these results are apparently at odds with what 
has been recently reported 92, it is possible that ASP5 is preferentially active while the 
parasites are intracellular—and thus explain why we were unable to observe processing 
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during pulse-chase experiments but were consistently able to observe processing in 
western blots, where the lysates are made from intracellular parasites. On the other 
hand, we also see variable levels of processing from western blots, which suggest that 
proteolysis is happening during sample preparation. One possible explanation for this is 
that another secreted protease is responsible for the maturation of TgLCAT, and these 
two partners are being artificially exposed during lysate preparation. If this were the 
case, a secreted protein from the micronemes could rapidly convert a PV with 
accumulated full-length TgLCAT into its processed form just prior to egress. There are 
indeed proteases secreted from the micronemes (TLN4, SUB1) 84, 85, which could serve 
this purpose. Regardless, more detailed characterization on the role of processing in 
relationship to LCAT activity is required. 
 
3.4 Materials and Methods 
LCAT modeling and sequence analysis 
Phyre2 was used for template-dependent modeling of TgLCAT queried with amino 
acids 39–763 [minus the “inserted element” at 465-605], allowing the program to identify 
the best candidate template for modeling. Human lysosomal phospholipase A2 (LPLA2; 
Protein Data Bank code 4X91) was the highest scoring template upon which the 
structural model was built. Models visualization was performed with PyMOL. For the 
phylogenetic analysis, LCAT orthologues were identified via BLAST search using the 
TGME49_272420 sequence from the EuPathDB. Representative eukaryotic sequences 
were chosen from major groups via BLAST of the non-redundant protein database 
(blast.ncbi.nlm.nih.gov). To assess the phylogenetic relationship between the 
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homologues, a multiple sequence alignment of LCAT proteins was performed using 
MUSCLE, from which a bootstrap neighbor-joining phylogenetic tree using p-distance 
method and 1,000 bootstrap support were generated (MEGA version 6.0 software). A 
schematic tree was predicted by neighbor-joining using the LCAT sequences from 
Hammondia hammondi (HHA_272420), Neospora caninum (NCLIV_034880), 
Sarcocystis neurona (SN3_00202440), Eimeria tenella (ETH_00005915), Vitrella 
brassicaformis (Vbra_21178), Gregarina niphandrodes (GNI_089950), Plasmodium 
berghei (PBANKA_112810), Plasmodium falciparum (PF3D7_0629300), Plasmodium 
knowlesi (PKH_111960), Plasmodium vivax (PVX_114565), Trichuris trichiura 
(GI:669226237), Arabidopsis thaliana (GI:30689946), Xenopus laevis (GI:148229443), 
Alligator mississipiensis (GI:944443680), Homo sapiens (AAB34898.1), and Mus 
musculus (AAL11035). R software (package ‘ape’) was used to draw the dendograms. 
 
Lysate preparation and immunoblotting 
Lysed parasites were filter purified, chased and washed with 4ºC PBS, and 
resuspended to a concentration of 107 tachyzoites / 5 µl in 100ºC sample buffer + 2ME. 
For SDS-PAGE separation, 5 x 107 tachyzoites were loaded per lane on a 10% gel, 
following electrophoresis samples were transferred to a polyvinylidene fluoride (PVDF) 
membrane. Membranes were blocked with 10% nonfat milk, probed with mouse anti-
LCAT 1:3500, rat anti-HA 1:1000, or rabbit anti-actin 1:200000 in 1.25% nonfat milk + 
PBS-Tween 20 0.2%, washed in PBS-T, and probed with horseradish peroxidase 
conjugated secondary antibodies at 1:1000. Blots were incubated with enhanced 
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chemiluminescent substrate (Super Signal West Pico, Pierce) and exposed to film or 
captured with a chemiluminescent imager (Syngene). 
 
Metabolic labeling and immunoprecipitation. 
Pulse-chase labeling was performed as follows. T25 tissue culture flasks of confluent 
HFFs were infected with 3.5 x 106 freshly lysed tachyzoites. The following day parasites 
were liberated by mechanical lysis by serial passage through a 20G needle, and then 
purified in cysteine and methionine free DMEM (Gibco) + 1% FBS (Gibco) at 1 x 108 
parasites / ml. Metabolic labeling was done at 37 kBg/ml of 35S [methionine + cysteine] 
for 10 minutes at 37ºC. Following labeling, samples were chased with 5 mM [methionine 
+ cysteine] in DMEM + 1% FBS and 100 µl samples were collected at 0, 15, 30, 45, and 
60 min. Parasites collected at each time point were then spun down and lysed in RIPA 
buffer (50 mM Tris-HCl [pH 7.5], 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS, 
150 mM NaCl, supplemented with DNase and RNase) plus protease inhibitors (Roche), 
followed by immunoprecipitation with rat anti-HA, rabbit ant-M2AP, or rabbit anti-GRA4 
antiodies. Following immunoprecipitation, samples were run on 10% SDS-PAGE gels, 
which were then incubated in Amplify (Amersham) and dried in cellophane. Dried gels 
were exposed to a phosphoimaging screen overnight and imaged on a Typhoon 
Imaging system. 
 
Baculovirus expression and cloning 
The TgLCAT coding sequence was amplified from Toxoplasma cDNA using the 
following primers ajsP113 TACTTCCAATCCAATGCATTGTCGTCGCCTTTCTCC, and 
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ajsP114 TTATCCACTTCCATTACGCGTAGTCCGGGAC. The resulting amplicon (2 kb) 
was gel purified and LIC cloned into bacuolovirus expression vecter Ac7, provided by 
Clay Brown at the High Throughput Protein Lab at the University of Michigan, following 
the protocol described previously 86. Following cloning, protein was expressed by the 




This study was carried out in strict accordance with the Public Health Service Policy on 
Humane Care and Use of Laboratory Animals and Association for the Assessment and 
Accreditation of Laboratory Animal Care guidelines. The animal protocol was approved 
by the University of Michigan’s Committee on the Use and Care of Animals (Animal 
Welfare Assurance #A3114-01, protocol #09482). All efforts were made to minimize 
pain and suffering of the mice. 
 
Parasite culture 
Toxoplasma tachyzoites were maintained by serial passaging and growth in human 
foreskin fibroblasts (HFF) cells. Cell cultures were grown in Dulbecco’s Modified Eagle 
Media (DMEM, source) supplemented with 10% fetal bovine serum (FBS, source), 2mM 
glutamine and 10 mM HEPES and grown in 5% CO2 at 37ºC. Parasites were liberated 
by scraping the infected HFF monolayer and passage through a 27G needle. The 
liberated parasites were then filtered through a 3 µm size filter (Millipore), counted on a 
hemocytometer, and added to HFFs at the appropriate density. For routine culture of 
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the parasites, 5 drops of naturally egressed parasites were passed into fresh host cells 
in a T25 flask. 
 
Transacylace activity assays 
Recombinant protein was incubated with DOPC/sulfatide/NAS liposomes at 37ºC at pH 













Discussion and Future Methods of Studying Egress 
 
4.1 Discussion 
Egress from the infected host cells represents one of the key events in the 
intracellular lifecycle of all intracellular pathogens. For Toxoplasma gondii, and its 
Plasmodium spp. relatives, this process is accomplished via a cytolytic mechanism. 
Despite the prominence of this step and the downstream consequences of host 
damage, little is known about this event mechanistically. The detailed molecular 
mechanisms of egress have been slow to emerge, and currently only one egress 
effector protein, PLP1, has been mechanistically characterized. This work focused on 
determining the role of another secreted egress effector, TgLCAT, during this enigmatic 
process. While the mechanistic role of TgLCAT has remained elusive, this work has led 
to an important clarification of the existing literature by showing that TgLCAT does not 
have a role in virulence or parasite replication, but instead this protein primarily acts 
during egress—and its phenotype may be tied to a shift in the calcium signaling 
pathway. 
Given the subtle phenotype seen during in vitro assays, and the lack of a 
phenotype altogether during in vivo experiments, further pursuit of a mechanistic role for 
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TgLCAT during toxoplasmosis is difficult to justify. However, this molecule does contain 
an interesting feature that is worth further exploration: the unique inserted element that 
interrupts LCAT’s PLA2 domain. The presence of this element in a subpopulation of the 
apicomplexans suggests that in the coccidians, this element may be responsible for 
differences in activity between groups, i.e. transmigration in Plasmodium spp. vs. 
egress in Toxoplasma. Assuming the inserted element is responsible for regulating 
LCAT activity during intracellular replication, testing the consequence of deleting the 
element entirely (LCAT vs. LCAT∆insert), and the effect of adding this element to 
heterologous proteins of known function (characterized GRAs, fluorophores) could 
reveal important information in terms of change of protein function or localization. While 
these discoveries would not likely be of high impact in regards to TgLCAT, these 
insights could lead to the development of valuable tools—for example by allowing 
researchers to design experiments that differentially regulate the activity or localization 
of a protein of interest, for example. Additionally, this impact of TgLCAT may be 
confined to certain stages of the parasite. For example, the Plasmodium homologue of 
TgLCAT seems to function differently in the sporozoites (transmigration) 34 than in the 
liver-stage (egress)52. It is therefore a possibility that TgLCAT has a relatively minor role 
in the tachyzoites, and a more prominent role in the Toxoplasma bradyzoite or 
sporozoite—stages that are currently very difficult to work with in the laboratory. It is 
puzzling that to date only PLP1 has been identified as a “true” egress effector. Despite 
the work of several labs conducting independent forward genetic screens to identify 
egress factors, these studies have reliably uncovered proteins that are involved in 
calcium signaling and/or microneme secretion. The simplest explanation for this 
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observation is that only PLP1 and parasite motility (motility is a result of microneme 
secretion) are needed for tachyzoite egress in Toxoplasma. One could argue that 
egress is still a vital process in the lifecycle based on the profound loss of virulence in 
the PLP1 knockout strains. Mice that are infected with ∆plp1 tachyzoites, when 
compared to wild-type, exhibit a ≥ 105 fold loss in virulence 10. However, it is important 
to note in this study, there were similar parasite loads between mice infected with wild 
type vs. ∆plp1 parasites, which indicates that despite the egress phenotype seen during 
in vitro assays, ∆plp1 mutants are clearly able to effectively complete the lytic cycle in 
vivo. Furthermore, during routine tissue culture passage of these lines, there are no 
defects in the ability of ∆plp1 parasites to complete the lytic cycle as measured by 
parasite outgrowth. While it is true that ∆plp1 parasites form smaller plaques when 
grown on a cell monolayer, these results also have an alternative explanation; parasites 
that struggle to egress (∆plp1), have a secondary invasion defect 11. Meaning that when 
∆plp1 parasites are allowed to naturally egress (vs. when they are mechanically 
liberated from a monolayer), there is a defect in the ability of the naturally egressed 
parasites to re-invade a host cell. Therefore, the defect in plaque size seen in the ∆plp1 
parasites cannot be specifically attributed to defects in egress or defects in invasion. It 
is possible the smaller plaques are a result of an invasion defect, because it is not 
apparent how a failure to egress from a monolayer of fibroblasts would be 
consequential—as these cells lack the innate defense mechanisms to clear T. gondii. 
Important questions to consider include: what is the fate of parasites that are unable to 
egress? Infected cells typically undergo a necrotic cell death—in which case the 
parasite would become extracellular. In other cases, parasites that fail to egress could 
    57 
presumably be targeted by phagocytic cells—and even the result of this is not directly 
clear, some strains of T. gondii have demonstrated an ability to subvert phagocytosis. 
This process allows the parasites to “invade” from within the phagosome and form a 
novel, productive PV inside which the parasite can replicate. Therefore even in the 
event of engulfment by phagocytes, T. gondii can still form a novel PV and turn the 
tables by parasitizing these immune cells.  
T. gondii has an actinomycin motility system that has long been recognized for its 
contributions to both invasion and egress. However, work done using chemically 
paralyzed parasites revealed that in the absence of motility, the tachyzoites were still 
able to egress by lysing the host cell. While these results remain compelling, it is 
important to recognize that in these experiments it would be very difficult to distinguish 
parasite egress from host cell necrosis. For example, in these experiments, infected 
monolayers were treated for a prolonged period (10 minutes) with A23187, a calcium 
ionophore 17. It is difficult to determine if the egress observed in these cases were due 
to parasitic secretion of effector proteins, or if the chemical treatment lead to host cell 
death, or even a combination of the two. Reportedly, A23187 is highly toxic to 
mammalian cells when treated at slightly higher doses (10-fold) for 60 minutes, and this 
toxicity is presumably a result of plasma membrane damage 88. It is important to 
recognize recent work and how these data fit into the current egress model as well. 
Recent work by the Meisner group has involved making gene knockout for components 
of the motor system in Toxoplasma, including actin and myosin. These genetically 
paralyzed tachyzoites are still able to invade but are unanimously unable to egress 18.  
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Regardless of whether or not egress is a crucial process to the tachyzoite 
lifecycle, or a dispensable one, it is plausible that studying egress in vitro via the 
commonly used assays in our field is not ideal. There are at least three shortcomings 
regarding the current in vitro models for egress. First, the cell line most commonly used 
for both routine culture and most in vitro experiments is the human foreskin fibroblast 
(HFF). This is done primarily out of convenience—these cell lines are easy to maintain 
in culture and are ideal for microscopy because of their flat morphology. However, this 
is not a cell type that Toxoplasma will likely infect in the course of a natural infection. 
Although Toxoplasma has a very broad tropism—and will infect virtually any nucleated 
cell type, what is observed during murine infection are predominantly infected 
monocytes and macrophages. In contrast to this, it is known that HFF cells begin to lose 
many of their cellular intrinsic defense mechanisms against intracellular pathogens at 
relatively low passage numbers, which makes them further unsuitable when performing 
in vitro assays. One potential way of addressing this would be to perform egress assays 
in a context that more accurately represents what we do see from in vivo studies—
namely by choosing immune cell lines to replace HFFs, and performing these assays in 
inflammatory conditions that mimic the strong inflammatory immune response 
characteristic of Toxoplasma gondii infection. Interferon gamma is a key cytokine 
controlling the response 89; therefore it would be more appealing to perform egress 
assays in the presence of this molecule and in cell types that are able to appropriately 
respond to IFN gamma stimulation. Supporting this in terms of the importance to 
TgLCAT, it has been shown that human LPLA2 is preferentially active on oxidized 
substrates 87. If this is true for the Toxoplasma homologue then it could be that TgLCAT 
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is more active in oxidized environments, i.e. activated macrophages or monocytes, and 
studying egress in these cells would elicit a stronger phenotype. 
Secondly, current methods of studying egress rely largely on inducing 
intracellular parasites to egress in response to pharmacologics that activate intracellular 
calcium signaling in the parasite. This is done largely by necessity since egress is a 
very dynamic process, and when allowed to occur naturally, this process typically 
occurs asynchronously around 48 – 60 hours post-infection. Induction is normally done 
with zaprinast, a phosphodiesterase inhibitor, or calcium ionophores such as ionomycin 
or A23187. One pitfall present in the use of all of these agents, is the off-target effects in 
the host cell, and their physiological relevance. Zaprinast, for instance, was originally 
developed by Pfizer as a drug to treat erectile dysfunction; it was abandoned due to the 
high number of off target effects when tested on mammalian cells 90. So while it is very 
effective in eliciting a calcium response from the parasite, it is also hitting a number of 
phosphodiesterases within the host cell, with unknown consequences. The same can 
also be said of the calcium ionophores—these compounds work by allowing calcium to 
freely cross cell membranes in a non-specific manner. Again these compounds elicit a 
strong response from the parasite, but certainly impact the host cell as well by liberating 
calcium stores from the ER, lysosomes, and mitochondria, for instance.  
While off-target effects are a cause for concern when using any type of drug, it 
makes it especially difficult to tease apart subtle phenotypes when studying egress, 
because it is difficult to determine how much of the phenotype is coming from the 
parasite vs. the host. For example, host calpain proteases are known to play a positive 
role in facilitating egress of T. gondii. These proteases are activated by free calcium, 
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and are therefore likely to be activated during egress stimulation with calcium 
ionophores. This clouds the interpretation of the results, especially in a system studying 
host:pathogen interactions, because presumably any phenotype observed in egress 
could be due to either the parasites response, or to an altered host calpain response.  
What we do know about egress in vivo, is that egress can be stimulated by the 
interaction of an infected cell with an immune cell 31. For example, CD8 T-cell 
interaction with an infected cell can be a trigger that induces parasite egress. This is 
presumably a way for the parasite to sense that its environment is under imminent 
threat, and respond appropriately. There are at least two mechanisms which describe 
this event, signaling through Fas ligand 32, or perforin attack31. A potentially improved 
method of studying egress in vitro would replace pharmacological induction of egress 
with a biological method. Infected cells, either transformed to express the appropriate 
receptors or chosen for endogenous expression of these molecules, could either be 
stimulated by addition of the recombinant ligands or addition of activated immune cells 
that express these molecules. This manner of induction would be a more appropriate 
approach to studying egress, because it would mimic the actual events that stimulate 
egress during toxoplasmosis as accurately as possible, and furthermore this would 
induce a response that utilizes relevant signaling pathways and would presumably elicit 
responses that are of a natural level. Treating monolayers in this manner may be more 
akin to a surgeon precisely using their scalpel vs. hitting the infected cells with a 
sledgehammer of calcium ionophore that robustly and indiscriminately exerts responses 
in both the host and parasite. 
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Finally, we must question the traditional method of allowing parasites to replicate 
within HFFs for ~30 hours before inducing egress. This is done partly out of tradition, 
and partly because at these later timepoints the parasites respond better to all 
stimulants—and in this context egress from the wild type parasites is very robust. 
Unfortunately, existing in vivo and ex vivo data suggests that during toxoplasmosis, 
parasites undergo rapid cycles of invasion and egress, on the order of a few hours (T1/2 
= ~3hours) 31.  
Traditionally egress was thought to be a passive event, as parasite growth and 
replication within a host cell eventually strained the host cell to the point of physical 
rupture. While we now know that this is not the case, it is likely that allowing parasite to 
replicate and form “large” vacuoles of 32+ parasites, puts a mechanical strain on the 
host cell to unknown effect. This is especially apparent while attempting to study 
“natural egress” in vitro—which is typically done by trying to observe egress of vacuoles 
at nearly 60 hours post infection. It is unlikely that during the inflammatory stages of 
toxoplasmosis, the parasites never are within a single cell for that amount of time. 
Furthermore in cell types like monocytes and macrophages this amount of replication 
would be impossible as there is not the physical space necessary for 32 parasites to 
reside within—unlike the comparatively large HFF cells. Instead of performing egress 
assays at 30 hours (or later) post infection, it would seem to be far more relevant to 
perform these studies on cells that have only been infected for a few hours, in order to 
more closely mimic conditions seen during in vivo infection. 
Traditionally egress has been a difficult event to study, in large part due to how 
little is known about the process overall, and due to it’s dynamic nature. Currently these 
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assays are done in a manner that works and is convenient, but one must question if 
perhaps these methods are too stimulating. This may explain why many genetic 
screens are failing to pick up loss of function in genes that have more mild phenotypes 
when compared to PLP1 or parasite motility. The development of a more fine-tuned 
approach would allow future work to uncover phenotypes associated with genes that 
have a minor impact. Additionally, these methods would allow for a more detailed 
mechanistic role of how these factors behave in different environmental contexts, i.e. 
Fas vs. Perforin attack, INF gamma vs. LPS, and even early vs. late time points. We 
must also consider that if further optimization and fine-tuning of in vitro methods to study 
egress still does not uncover additional effectors in this process, then either PLP1 and 
parasite motility are sufficient for parasite egress, or egress is not as crucial to the 
tachyzoite life cycle as originally thought. Which brings about another very interesting 
question: is egress crucial in any of the remaining parasite life stages? 
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